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 The incidence of metabolic syndrome and its side effects are increasing 
throughout the world. Diet plays a key role in reducing the risk of metabolic syndrome, 
possibly mediated by metabolic activity of the gut microbiota. Whole grains (WG) and 
fruits and vegetables (FV) are two food groups that are commonly promoted for their 
ability to reduce the risk of metabolic syndrome. However, these two food groups 
provide vastly different nutrients that likely impact health via different mechanisms. 
Therefore, the primary objective of this research was to determine the impact of 
consuming recommended amounts of whole grains and fruit and vegetables against a 
background of their typical diet on inflammatory makers and gut microbiota composition 
in overweight or obese individuals that have low intakes of these food groups. The WG 
treatment significantly reduced tumor necrosis factor and lipopolysaccharide binding 
protein (TNF-α and LBP), while the FV treatment reduced IL-6 and LBP. Both 
treatments induced individualized changes in microbiota composition, with the FV 
treatment causing a significant increase in α-diversity. Thus, WG and FV both have the 
capability of decreasing inflammation associated with metabolic syndrome, but by 
different mechanisms. A follow-up in vitro study was performed using the fecal 
microbiota collected from subjects in the WG and refined grain (control) treatment 
  
groups to gain insight into changes in metabolic activity of the microbiota that may help 
explain the reduction in inflammatory markers identified in the feeding trial. Microbiota 
collected at the end of the WG intervention tended to increase the fermentation of 
carbohydrates from WG compared with before the intervention. Correlation analysis 
suggested that changes in Corpococcus may be related to increased short chain fatty acids 
production by the microbiota and subsequent reduction in inflammatory markers. Thus, 
this in vitro approach enabled possible insight into the relationship between WG intake, 
changes in the gut microbiota, and reduced inflammation. 
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Chapter 1 Introduction 
It has been found that both whole grains (WG) and fruit and vegetables (FV) can 
reduce markers of metabolic disease, possibly mediated through activity of the gut 
microbiota (Martínez et al., 2013; North et al., 2009; Vetrani et al., 2016). However, no 
previous studies have compared these two food groups to determine their relative effects 
on human health. This thesis is focused on promoting gastrointestinal health and reducing 
subclinical inflammation in obese individuals though intake of WG products in 
comparison with FV. By comparing WG with FV, observations can be made regarding 
which food group may have the most positive impact on health.  
 Chapter 2 of this thesis reviews research that has been published about WG and 
FV. Key foci are clinical WG and FV interventions and epidemiological studies that 
address the metabolic benefits of WG and FV.   
Chapter 3 of this thesis presents results from a feeding trial comparing the 
metabolic effects of consuming the recommended levels of WG or FV in comparison 
with refined grains (RG) in an overweight/obese population with habitually low intakes 
of WG and FV. The objectives were to 1) perform a 6 week feeding trial with WG, FV 
and RG (control) treatments; 2) determine changes in inflammatory markers, fecal 
microbiota composition, and microbial metabolite concentrations after treatments; and 3) 
determine how changes in inflammatory markers may be related to changes in the gut 
microbiota composition during the interventions.  
WG and FV have a wide variety of nutritional benefits. Consumption of WG have 
shown to decrease inflammatory markers and increase beneficial bacteria in gut bacteria 
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(Ampatzoglou et al., 2016; Martínez et al., 2013; North et al., 2009). Epidemiological 
studies correlated WG consumption to lowering metabolic type diseases (D. et al., 2003; 
McKeown et al., 2009). FV interventions and epidemiological studies have connected FV 
to lowering risk of metabolic syndrome through decreased inflammation (Holt et al., 
2009; Mirmiran et al.,  2012; Yeon et al., 2012). Based on WG and FV epidemiological 
and intervention studies, I hypothesize that the WG intervention will be as effective in 
improving beneficial bacteria and reducing subclinical inflammation compared to a FV 
intervention, both of which will be better than RG.       
Chapter 4 of this thesis describes results from an in vitro fermentation experiment 
using stool samples collected from the individuals in the WG and RG treatments at 
baseline and at the end of the study. These stool samples were used as a source of gut 
bacteria for in vitro fermentation of pre-digested whole wheat flour to determine changes 
in carbohydrate fermentation and SCFA production by the microbiota as a result of the 
intervention. Previously, others have shown that individuals with higher habitual intake 
of plant foods (like WG and FV) harbored a microbiota that was better equipped to 
ferment the dietary fibers in WG and produce more butyrate compared with the 
microbiota from individuals with lower intake of plant foods (Brahma et al., 2017). 
Therefore, I hypothesize that the fecal microbiota collected from subjects after a WG 
intervention will be better able to ferment the dietary fibers in whole wheat and produce 
butyrate compared with before the intervention.  
The final chapter of this thesis includes overall conclusions and prospective 
research ideas.
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Chapter 2 
Abstract 
The importance and benefits of fruits and vegetables (FV) in a healthy diet is well 
accepted; however, the importance and benefits of whole grains (WG) are less 
recognized. WG and FV clinical interventions have shown to increase beneficial gut 
microbiota, increase short chain fatty acid (SCFA) production, and lower anti-
inflammatory markers. Epidemiological studies have also tied WG and FV to decreasing 
anti-inflammatory markers and lowering risks of obesity, metabolic syndrome, and 
associated diseases. What is less known is how whole grains, fruit and vegetables are 
lowering the risks for metabolic syndrome and such diseases. This review will explain 
and compare the key benefits of whole grain, fruit, and vegetables with evidence from 
clinical trials and epidemiological studies. The results will show that FV clinical trials 
tend to decrease anti-inflammatory markers and through epidemiological studies, WG are 
linked to decreased risks for obesity, metabolic syndrome, and associated diseases. 
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Introduction 
Fruit and vegetables (FV) contain a wide variety of vitamins, minerals, and 
polyphenols that can influence human health (Lampe, 1999). A few of these nutrients 
include vitamin C, folate, dietary fiber, beta carotene and flavonoids. Different FV have 
unique nutritional profiles; therefore, an assortment is recommend to promote health 
(Slavin et al., 2012) 
FV have been linked to lowering risks of metabolic syndrome by lowering 
inflammation. Correlations have been made to explain some interactions between fruit 
and vegetable components and inflammatory markers. Within a population of 265 
adolescent girls and boys, C-reactive protein (CRP) inversely correlated with intake of 
fruit, vitamin C, and folate. Interleukin 6 (IL-6) inversely correlated with intake of 
legumes, vegetables, beta carotene, and vitamin C (Holt et al., 2009). CRP and IL-6 are 
indicators of inflammation and are markers of increased risk of metabolic diseases 
(Marsland, McCaffery, Muldoon, & Manuck, 2010). 
Whole grain products contain the germ, endosperm, and pericarp (bran) of the 
seeds (Oldways Whole Grains Council, 2017). Whole grains contain dietary fiber, 
phytoserols, and vitamin E that have been shown to improve health through lowering 
blood cholesterol levels, heart disease, stroke, obesity, and type 2 diabetes (Anderson et 
al. 2009; Prasad 2011; Slavin et al., 2012).  
There have been numerous feeding trials to investigate the benefits of WG and 
FV. Many of these trials focus on individual food groups (vegetables or whole grains), 
rather than connecting different food groups. For instance, there are not many published 
studies comparing the benefits of WG and FV in a feeding trial. The purpose of this 
15 
 
 
review was to investigate the benefits of WG and FV with respect to lowering metabolic 
syndrome through inflammatory makers and gut microbiota composition. 
Benefits of Fruits and Vegetables  
Fruit and Vegetables 
There are over 4,000 different fruit and vegetables in the world. The 5 top fruits 
consumed in the U.S are bananas, apples, berries, melons, and oranges, and the top 5 
vegetables are potatoes, lettuce, onions, tomatoes, and carrots (“Produce for Better Health 
Foundation,” 2015). The reference daily intake (RDI) of FV is 5 servings (about ½ c 
each) (United States Department of Agricutlure, 2017).  
FV have a wide variety of nutrients that can help lower risks of metabolic 
syndrome. For instance, vitamin C plays major roles as a cofactor for several enzymes 
involved in the biosynthesis of collagen, carnitine, and neurotransmitters, helps  
metabolism of cholesterol to bile salts, and helps improve absorption of Fe by keeping it 
in its reduced state (Fe2+) (Carr et al.,1999). A cross sectional study was performed on 
22,671 adults, and it was found that high intakes (≥85 mg/day) of vitamin C and high 
physical activity can lower the risk of metabolic syndrome (Kim et al., 2016).   
Flavonoids are phytochemicals found in fruits and vegetables. There are over 20 
different flavonoids in fruits and vegetables (Harnly et al., 2006). Flavonoids have been 
associated to lower the risk of stroke, coronary heart disease, and markers of 
inflammation (Holt et al., 2009). Flavonoids have been shown to decrease plasma 
cholesterol, hyperinsulinemia, and blood glucose in diabetic rats (Mulvihill & Huff, 
2010).  
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Folate consumption has been associated with decreased risk of certain types of 
cancer, heart disease, and stroke (United States Department of Health & Human Services, 
2016). The RDI of folate is 400 mg/d, which assists with RNA and DNA synthesis and 
metabolizing amino acids. In a folic acid supplementation epidemiological study, meta-
analysis was able to indicate a 10% lower risk of stroke and 4% lower risk of overall 
cardiovascular disease (Y. Li et al., 2016).  
On average, fruit or vegetables have about 4 grams of dietary fiber per 100g 
depending on the FV (United States Department of Agriculture, 2017a). Depending on 
the type of fruit and vegetable the fiber content changes and the ratio of insoluble and 
soluble fiber changes as well. The main insoluble fibers in FV are lignin, cellulose, and 
xyloglucan, and the soluble fibers are inulin and pectin. Many epidemiological studies 
focusing on FV fiber have shown non-significant decreases in metabolic syndrome 
related diseases (N. M. McKeown et al. 2009; Rimm EB et al. 1996; Schulze et al. 2007). 
Fruit and Vegetables Clinical Trials and Epidemiological Studies 
 
There have been many clinical interventions that investigate the changes in 
immune responses and inflammatory markers in response to consuming FV (Table 1). In 
a low (1 serving per day) verses high (12 servings per day) fruit and vegetable diet 
clinical study, IL-6 was significantly decreased in the high fruit and vegetable diet and 
hs-CRP was increased in the low fruit and vegetable diet (Yeon et al. , 2012). This study 
also showed that there is a relationship between high fruit and vegetable diet and 
lowering lymphocyte DNA damage and proinflammatory cytokine production, which 
reduces risks of metabolic diseases. A study where subjects had an option of a wide 
variety of 8 servings of FV per day showed a significant decrease in hs-CRP (Watzl et al., 
17 
 
 
2005). In a dietary intervention with 10 g of broccoli sprouts with sulforaphane (225 
µmol concentration), the intervention was shown to significantly reduced IL-6 and TNF-
α and significantly lower hs-CRP (Mirmiarn et al. 2012). In a dietary intervention of wild 
blueberry juice (25g wild blueberry powder), it was shown that inflammatory markers 
were not significantly decreased but levels of endogenously oxidized DNA bases were 
reduced (Riso et al., 2013). These studies suggest that individual fruits and vegetables 
could have significant effects on inflammatory markers. These results suggest that people 
consuming increased levels of fruits and vegetables could potentially have lower 
inflammatory markers, thus, lower chances for inflammatory diseases. 
Large scale epidemiological studies have shown the benefits of high FV diets in 
reducing inflammatory markers and the risk of chronic disease (Table 3). Holt et al., 
(2009) was able to show inverse correlations between CRP and intake of fruit, vitamin C, 
and folate, as well as an inverse relationship between IL-6 with intake of legumes, 
vegetables, beta carotene, and vitamin C. The intake of fruit and vegetables has also been 
inversely linked to lowering risks of coronary artery disease and certain cancers (Riboli et 
al., 2003; Steffen et al. 2003). Clinical trials and epidemiological studies have shown the 
significant effects of FV on inflammatory diseases, cancer, and metabolic health.  
Benefits of Whole Grains  
Whole Grains 
The most commonly consumed whole grains are brown rice, wheat, oats, corn, 
rye, and barley. The most consumed whole grain products in the U.S are whole wheat 
bread, oatmeal, popcorn, whole grain cold cereal, and whole grain pasta (Oldways Whole 
Grain Council, 2015.).  The current recommendation of whole grains is at least three 
servings (1 serving = 1 ounce) per day. Certain whole grains are good sources of dietary 
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fiber, vitamin E, and phytosterols (Harvard School of Public Health, 2017). The main 
soluble dietary fiber in WG are, ß-glucan, and inulin, and the main insoluble dietary fiber 
are cellulose, arabinoxlyan, and lignin.  
Arabinoxlyan (AX) is a non-starch polysaccharide that is found in many cereal 
grains. It is the one of the most abundant polysaccharides in the cell wall (Mendis et al., 
2016).  In the body, purified AX helps control blood glucose and insulin and improved 
postprandial metabolic responses (Garcia et al., 2007). Bifidobacterium, Bacteroides, and 
Clostridium have shown significant increases in fermenting AX in the gut (Mendis et al., 
2016).  
The main source of ß-glucan is in the cell walls of barley and oats. Consuming 3 g 
or more ß-glucan per day has been shown to lower cholesterol levels (Anderson et al., 
2009). Other benefits include lowering dyslipidemia, hypertension, and obesity (Khoury 
et al., 2012). 
 Cellulose is an insoluble fiber that acts as a bulking agent that helps move food 
through the digestive system. This promotes regular bowel movement and can help 
reduce constipation. Cellulose can also be fermented in the gut by Rumminicous (J. et al., 
2013).  
One of the notable phytonutrients in whole grains is vitamin E. This antioxidant 
can inhibit lipid peroxidation and reactive oxygen species production. One study showed 
that vitamin E is linked to lowering CRP levels, which is a marker for inflammation 
associated with heart disease. Vitamin E can also lower cholesterol by down regulating 
HMG-CoA reductase in cholesterol synthesis (Parsad, 2011).   
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Phytosterols are plant based sterols that are a subgroup of steroids.  In whole grain 
products phyotserols reduce serum cholesterol (Salvin, 2003). They can inhibit dietary 
and biliary cholesterol absorption by displacing cholesterol from micelles which 
increases excretion. The average western diet includes 200-300 mg/d of plant sterols. The 
consumption of whole grains high in phytoserols, rye bread and wheat germ, could 
increase phytoserol level in the body. Consumption of 2-3 grams per day of phytoserols 
can lower an individual’s LDL by 10% (Mendis et al., 2016). 
Whole Grain Clinical Trials and Epidemiological Studies 
Although wheat-based food products, even those made with whole grains, have 
been implicated as causative agents for obesity, diabetes, and many other diseases in the 
popular literature (Davis 2011), scientific studies have found that wheat-based products 
lower the risk of type 2 diabetes and cardiovascular disease (Figure 2).  Some studies 
have investigated the influence of a diet rich in whole grain products on the gut 
microbiota composition (Costabile et al., 2008; J. et al., 2013; Martínez et al., 2013). 
Intake of high fiber whole grain rye bread and low fiber wheat bread in Finnish adults 
during a 12-week intervention decreased Bacteroides vulgatus, Bacteroides plebeius, 
and Prevotella tannerae and increased Clostridum cellulosi, Clostridum leptum, 
Anaerotruncus colihominis (Lappi et al. 2013). Clinical trial treatments with increased 
consumption of whole grain and wheat bran cereals increased Lactobacilli/enterococci 
and Bifidobacterium (Costabile et al., 2008). In another 17 week cross over study with 
treatments of whole grain, barely, and rice, Bacteroidetes decreased and Firmicutes 
increased (Martínez et al., 2013).  
Bacterial changes and SCFA production could be impacting anti-inflammatory 
markers. Ampatzoglou et al, (2016) showed a significant decrease in IL-10, CRP, and 
20 
 
 
insulin with a treatment of 80 grams whole grain per day. Through an intervention of 60 
grams of whole gran barely and brown rice, IL-6 was lowered (Martínez et al., 2013).  
Numerous epidemiological studies have been completed to investigate the intake 
of whole grains with metabolic health (Table 3). Whole grain consumption has been 
associated to lower body mass index (BMI), adipose tissue, and obesity (J. Davis, 
Alexander, & Ventura, 2009; Nicola M McKeown et al., 2009; van de Vijver, van den 
Bosch, van den Brandt, & Goldbohm, 2009). Ma et al. (2008) showed that total intake of 
dietary fiber, soluble fiber, and insoluble fiber was inversely related to CRP 
concentrations. Lastly, the intake of whole grains and their fibers have been associated 
with lower risks of cardiovascular diseases and Type 2 diabetes (D. et al., 2003; Rimm et 
al., 2004; M B Schulze et al., 2007). Through clinical interventions and epidemiological 
studies whole grains have shown to be associated with to lower metabolic syndrome 
through the interactions of gut bacteria fermentation and inflammatory markers.  
Comparison of WG and FV Diets  
Reviewing FV and WG clinical studies, FV treatments tended to show more 
consistent decreases in anti-inflammatory markers (Figure 2.1-2.2). Five out of the eight 
FV studies reviewed showed decreases in anti-inflammatory markers with FV treatment. 
Two out of the nine WG clinical trials reviewed showed decreases in anti-inflammatory 
markers with WG treatment. 
The WG treatments tended to show more significant changes in gut microbiota 
and production of SCFA. Four studies saw significant changes in gut microbiota. These 
changes were seen by increases or decreases in OTUs, increased microbial diversity, and 
changes in individual taxa. Five studies had changes in SCFAs or branched chain fatty 
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acids (BCFAs). Most studies involving FV did not report changes in gut microbiota and 
SCFA production. Only 1 FV study reported changes in the gut microbiota, and this was 
an overall bacterial community shift. 
Not many intervention studies have shown the relationship between increasing 
beneficial bacteria with the link of decreasing anti-inflammatory markers.  Martinez et 
al., (2013) showed this relationship with a treatment of 60 grams of whole grain barely 
and brown rice by an increase in the ratio of Firmicutes/Bacteroidetes, and a change in 
abundance of the genus Blautia with a decrease of IL-6. This shows that certain bacteria 
could have an impact on lowering anti-inflammatory markers. On the contrary other 
studies have shown that Firmicutes/Bacteroidetes do have impacts on certain fibers and 
obesity could impact the certain bacteria ratios like Firmicutes/Bacteroidetes (Brandt et 
al., 2012; Flint et al., 2012).  
Throughout the FV and WG clinical trials there are variable results. Each clinical 
trial had a unique treatment to their study. In the FV trials some studies were 
investigating certain FV while others were investigating a wide variety of FV. This could 
be one of the main causes of their variable results. The WG interventions also had studies 
focusing on a particular food option as well as using a wide variety of WG. The 
treatments also were giving different levels of whole grains or fiber. All these factors 
would be creating the variable results.  
Through the reviews of epidemical studies where both whole grain, fruit, and 
vegetable intakes were analyzed, WG intake showed more significant relationships with 
metabolic syndrome and associated diseases. Five out of the five studies comparing WG 
and FV within the same study showed WG intake was more strongly related to reduced 
22 
 
 
risks of cancer, obesity, and cardiovascular diseases. Thus, it can be concluded that FV 
clinical treatments have shown greater reductions in anti-inflammatory markers, which 
help lower metabolic syndrome compared to WG consumption, while epidemiological 
studies have linked WG consumption to reduced risk of metabolic disease more so than 
FV consumption.
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Author Subject 
Characteristics 
Feeding Trial and Treatments 
options 
Time periods Not Significant 
Results 
Significant Results 
Basu et 
al., 2010 
Twenty-seven 
subjects with 
metabolic 
syndrome, 2 
males and 25 
females; BMI: 
37.5±2.15 
kg/m2; age: 
47.0±3.0y 
4 cups freeze-dried 
strawberry beverage (50g 
freeze-dried strawberries ~ 3 
cups fresh strawberries in 2 
cups water 
Eight weeks in a 
randomized 
controlled 
glucose, 
triglycerides, HDL-
cholesterol, blood 
pressure, and waist 
circumference, 
dietary intake 
differences 
↓ total and LDL-
cholesterol, vascular cell 
adhesion molecule-1 
(VCAM-1), 
Li et al. 
2009 
12 women and 
5 men healthy, 
nonsmoking 
men and 
women, 20– 40 
y old, and 
recruited on the 
basis of 
GSTM1, 
GSTT1, and 
4 diets 
1) low-phytochemical basal 
diet devoid of fruits  
and vegetables and whole- 
grain, high-fiber foods [major 
food items consumed 
included bagels, pasta, white 
rice, ready-to-eat cereal, 
dairy 
2) a “single-cruciferous” diet 
[i.e. basal diet + 7 g 
Randomized, 
crossover, 
controlled feeding 
study, 2 14d intake  
Total energy,  
Carbohydrate, Fat,  
Protein,  
Overall bacterial 
community composition 
differed between the 2 
consumption periods 
Bacterial community was 
individual specific in 
vegetable diet 
↑ Urinary TIC excretion, 
fiber consumption 
tRFLP fragments that 
were significant 
Table 2.1 Review of Clinical Trials with Fruit and Vegetables Interventions 
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CYP1A2 
genotypes. 
cruciferous vegetables/(kg 
body weight×d) 
3) “double-cruciferous diet” 
[i.e. basal diet + 14 g 
cruciferous vegetables/(kg 
body weight×d) 
4) a mixed diet [i.e. basal diet 
+ 7 g cruciferous 
vegetables/(kg body 
weight×d) and 4 g apiaceous 
vegetables/(kg body 
weight×d) 
correlated with double 
vegetable Firmicutes, 
Bacteroidetes, and 
Actinobacteria  
Mirmiran 
et al. 2012 
81 type 2 
diabetic 
patients,  
Broccoli sprouts powder 
(BSP) with high sulforaphane 
concentration 
Treatments 
1- 10g/d 
2- 5g/d 
3- placebo 
Random 4 week 
study 
Fasting blood 
glucose 
↓ C-reactive protein in all 
BSP groups 
↓ non-significant 
decrease in IL-6 ad TNF-
α between treatment 
groups but significant in 
group A 
Ngondi et 
al. 2009 
102 healthy, 
overweight 
and/or obese 
volunteers 
150 mg of IGOB131 (wild 
African Mango extract) twice 
a day 
Randomized, 
double-blind, 
placebo 
controlled design 
for 10 weeks 
All results were 
significant 
↓ C-reactive protein , 
LDL, total cholesterol, 
weight, waist, leptin,  
Glucose, adiponectin 
Pierce et 
al. 2007 
3088 women 
previously 
treated for early 
stage breast 
cancer who 
were 18 to 70 
Telephone counseling 
program, cooking classes, 
and newsletters targeted to 
get participates to consume 5 
vegetable servings, 16 oz 
vegetable juice, 3 fruit 
Multi-
institutional 
randomized 
controlled trial of 
dietary change 
baseline 
demographics, 
characteristics of 
the original tumor, 
baseline dietary 
pattern, breast 
cancer treatment 
↑servings of vegetables, 
+65%; fruit, +25%; fiber, 
+30%, and energy intake 
from fat, -13%. 
No other significant 
changes 
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years old at 
diagnosis 
servings and 30 g of fiber a 
day 
Riso et al. 
2013 
20 Male, 
healthy subjects 
with at least one 
risk factor for 
cardio vascular 
disease (CVD) 
based on 
American Heart 
Association 
guidelines, 
needed to 
consume2< >5 
portions of 
FV/day) 
WB-25 g of wild blue berry 
powder mixed in 250 ml of 
water 
PL -250 mL water, 7.5 g 
fructose, 7 g glucose, 0.5 g 
citric acid and 0.03 g 
blueberry flavor 
 
6 week cross-
over design, 6 
week wash out 
period 
 
 
Vitamin C, folate, 
Vitamin B12, blood 
pressure, plasma 
total nitric oxide 
and soluble 
vascular cell 
adhesion molecule-
1, weight, BMI, 
glucose, TG, LDL, 
HDL, IL-6, CRP, 
TNF-α 
No significant results 
besides reducing the 
levels of endogenously 
oxidized DNA bases 
Watzl et 
al. 2005 
Sixty-four 
healthy men, 
nonsmoker and 
didn’t use 
dietary 
supplements or 
medication 
1 of 3 treatment groups 
1) 2 servings/d 
2) 5 servings/d 
3) 8 servings/d 
Vegetable intake included 
carrots, green beans, peas, 
broccoli, zucchini, tomatoes, 
kohlrabi, Brussels sprouts, 
red cabbage, cauliflower, 
spinach, corn, and salsifies. 
Salad intake included lettuce, 
tomatoes, carrots, corn, 
radishes, cucumbers, fennel, 
and cabbage. 
Randomized 
longitudinal trial 
of two 4-wk 
treatments 
Plasma Vitamin C, 
Vitamin E, weight, 
BMI, energy intake, 
protein, fat, 
carbohydrates, 
cholesterol, LDL, 
HDL, TAG, blood 
glucose, IL-2, 
interferon, IL-13, 
IL-12, TNF-α, NK 
cell cytotoxicity 
(%) NKp46+, CD3-
/CD56+, CD3+, 
lymphocyte 
proliferation 
↓ C-reactive protein in 
the treatment with 8 
servings/d of FV a day 
compared with 2 
servings/d 
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Fruit intake consisted of 
apples, pears, kiwis, bananas, 
peaches, nectarines, cherries, 
strawberries, and red 
currants. 
Yeon et 
al., 2012 
22 overweight 
women,  non-
smoker and 
didn’t use 
dietary 
supplements or 
medication 
Low FV diet 1 serving  of 
fruits and 1 serving  of 
vegetables  
High FV diet- 6 servings of 
fruits and 6 serving of 
vegetables The composition 
of vegetable and fruit in high-
VF diet consisted of 2 
servings of dark green 
vegetable; 2 servings of dark 
orange vegetable; 2 servings 
of dark red product; 2 
servings of other vegetables; 
2 servings of vitamin C-rich 
fruits/ juices (e.g., orange, 
strawberries) 
2 week dietary 
treatment with a 2 
week wash out 
 Significant change in 
decreasing IL-6 and IL-1 
between treatment 
groups 
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Author Subject 
Characteristics 
Feeding Trial Treatments 
options 
Time 
periods 
Not Significant 
Results 
Significant Results 
Ampatzo
glou et 
al. 2016 
12 men, 21 women; 
ages 40–65 y, BMI: 
20–35 kg/m2, 
habitual WG 
consumption <24 g/d 
WG 
High diet- >80 
g/day 
Low diet-16 g/day 
Bread, rice, pasta, 
snacks, breakfast 
cereals 
6 week 
cross over 
study 
IL-1, IL-6, IL-8, 
TNFα,  CD8+, 
ghrelin, GIP, GLP-1, 
glucagon, leptin,  
↑ WG Consumption 
↑ Fiber intake 
↓ IL-10, CRP, insulin, CD4+ T 
cells, C-peptide, PAI-1 
Brownlee 
et al. 
2010 
316 18-65 years, BMI 
25,  consume <30 g 
WG/;d 
Control (no 
dietary change), 
intervention 1 (60 
g WG/d for 16 
weeks) and 
intervention 2 (60 
g WG/d for 8 
weeks followed by 
120 g WG/d for 8 
weeks) 
An option of 
whole wheat 
bread, shredded 
wheat, cheerios, 
porridge oats, 
brown basmati 
rice, whole wheat 
pasta, weetabix 
porridge, oat bar, 
chips 
16 week  
randomized, 
controlled 
dietary 
intervention 
Total cholesterol, 
HDL, LDL, TAG, 
glucose, insulin, 
NEFA, QUICKI, R-
QUICKI, sialic acid, 
CRP, IL-6, 
fibrinogen, PAI-1, 
ICAM-1, VCAM-1, 
E-selectin, systolic 
BP, diastolic BP, 
weight, waist, body 
fat percentage 
No changes in biomarkers of 
CVC health 
↑ WG Consumption 
Good compliance 
 
Cooper 
et al., 
2017 
25 female and 21 
male healthy adults; 
 between the ages of 
19 to 46 years with 
BMI 20 to 28 kg/m2, 
“low whole grain 
consumers” < 1 
serving of whole 
Based on 
estimated energy 
output ex:2000 
kcal per day WG -
13.7 g fiber/d 
RG- 4.2 g fiber/d 
 
Bread, rice, pasta, 
snacks, breakfast 
cereals, tortilla, 
baking mixes 
 
6 week 
study  
randomized, 
controlled 
dietary 
intervention 
BMI, HDL, 
triglycerides, 
gastrointestinal 
symptoms, 
microbiota relative 
abundance in a 
particular taxa,  
No significant changes in gut 
bacteria 
↓ LDL, non HDL cholesterol, 
fasting blood glucose 
↑ bowel movement  
Table 2.2 Review of Clinical Trials with Whole Grains Interventions 
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grains/whole grain 
products per day,  
Costabile 
et al. 
2008 
32 healthy adults 48 g breakfast 
cereal 
Whole grain 
Wheat bran 
cereal Double-
blinded 
randomized 
crossover 
study, 6 
week 
Feacal SCFA,, fasting 
blood glucose, 
insulin, total 
cholesterol, TAG,  
HDL, stool habits 
↑ Bifidobacteria and in whole 
grain cereal 
↑ Lactobacilli/enterococci with 
whole grain and whole bran 
cereal 
↑ WG Consumption 
↑Feurlic acid both treatments 
Lappi et 
al., 2013 
25 males, 26 females; 
40–65 y, a BMI of 
26– 
39 kg/m2, and at least 
3 other features of 
metabolic syndrome:  
RG- Rye breads 
high in fiber 
WWB – refined 
wheat breads low 
in fiber 
Breads randomized, 
parallel, 2-
arm 12-wk 
intervention 
whether 
Intestinal microbiota 
composition did not 
significantly differ 
between the groups, 
certain nutrients,  
 
↑ WG Consumption 
↓ plasma  Androgen receptor 
Martinez 
et al., 
2013 
17 females and 11 
males healthy adults; 
 age 25.9±5.5 years 
WGB- 60 g of 
whole grain barely 
BR- 60 g of brown 
rice 
WGB+BR- 30 g 
brown rice, 30 g 
of whole grain 
barely 
Whole grain 
barely , Brown 
rice 
randomized 
cross-over 
trial with 
four-week 
treatments 
Cholesterol, HDL, 
non-HDL, hs-CRP, 
LBP, fasting blood 
glucose and insulin, 
microbial diversity 
Chao1,  
↑ microbial diversity Shannon’s 
and Simpson’s indices 
↑ Firmicutes, Incertae Sedis 
XIV,Blautia, Roseburia, 
Bifidobacterium, Dialister 
↓ Bacteroridetes, 
Bacteriodaceae, 
Porphyromonadaceae, 
Odoribacter 
↓OUT Odoribacter splanchnicus 
↑Eubacterium rectale, Roseburia 
faecis, Roseburia intestinalis, 
Blautia wexlerae, Blautia spp, 
Eubacterium rectale 
↓ in IL-6 in BR, BR+WGB 
treatment groups  
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McOrist 
et al. 
2011 
16 males, 30 females; 
age 55.9 ± 2.0 y 
(range 31–66); body 
weight 79.5 6 3.6 kg 
(range 57–109). 
Illnesses and 
participants on 
antibiotics were 
excluded 
The NSP diet ~25 
g of NSP/d- as 50 
g BranPlus, 50 g 
cooked carrots, 50 
g couscous, and 2 
g unprocessed 
bran  
The RS diet 
supplement ~22 g 
of RS/d - 25 g of 
NSP/d as an 
extruded, high-
amylose barley 
breakfast cereal, 
50 g of a 
commercial 
canned legume 
preparation, 50 g 
Greenwheat 
Freekeh and 20 g 
Hi-maize  
Carrots, couscous, 
bran, barely 
breakfast, legume 
hi maize, freekeh 
randomized 
cross-over 
study, 4 
week 
Age, weight, height, 
BMI, diet, 
propionate, ammonia, 
fecal, pH and 
moisture 
↑ acetate, butyrate, and total 
SCFA in RS diet compared to 
NSP diet and entry 
Fecal butyrate and ammonia 
excretions were positively 
associated 
↑ fecal weight 
 
Sheflin et 
al. 2015 
7 adults,   
no history of food 
allergies or major 
dietary restrictions, 
not currently taking 
cholesterol-lowering 
medications or non-
steroidal anti-
inflammatory drugs 
(NSAIDs) 
SRB-7 meals and 
6 snack options  
with 30 g/d of 
SRB 
Non SRB-7 meals 
and 6 snack 
options  with 
similar nutrient 
content but no 
SRB 
Meals or snacks 
made with heat 
stabilized rice bran 
(SRB)  
four-week, 
pilot, 
randomized-
controlled, 
single-
blinded 
dietary SRB 
intervention 
study 
Phyla level bacteria, 
SCFA, acetate, 
propionate, , valeric, 
caproic and heptanoic 
acids were 
Increases in eight operational 
taxonomic units (OTUs), 
including three from 
Bifidobacterium and 
Ruminococcus genera 
↑Isovalerate, isobutyrate, 
secondary bile acids in SRB 
↓Butyrate 
Various stool metabolites that 
had significant correlations 
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Vanegas 
et al. 
2017 
49 men and 32 
postmenopausal 
women [age range: 
40–65 y,  BMI from 
20 to 35,  a report of 
the consumption of a 
low-fiber diet (men: 
,<7 g/1000 kcal; 
women: ,8 g/1000 
kcal) for >2wk before 
enrollment 
Meals high in WG 
(16 g/1000 kcal) 
or RG (8 g/1000 
kcal) 
Western Style 
Meals- high 
protein and high 
fat 
2 week run 
in then 6 
week diet 
Stool characteristics, 
propionate, butyrate, 
α and ß-diversity, 
relative abundance at 
phyla level, IgA, 
DTH, IFN, IL-17, 
TNF-α, IL-6, TGF-ß, 
white blood cells, 
lymphocytes, 
monocytes, 
eosinophils, ba- 
sophils, or 
neutrophils 
WG compared to the RG diet 
↑plasma total alkyresorcinols, 
stool frequency, Changes in 
acetate and total SCFA, 
percentage of terminal effector 
memory T cells  and LPS-
stimulated ex vivo production of 
tumor necrosis factor-a, 
Positive correlation between 
Lachnospira with acetate and 
butyrate 
 
Vetrani 
et al. 
2016 
23 men and 31 
women 
overweight/obese 
with metabolic 
syndrome 
Whole grain cereal 
Refined grain 
cereal 
Cereal products 12 week 
dietary 
intervention 
glucose, BMI, 
HOMA, TAG, 
cholesterol, HDL,  
hs-CRP, IL-1 ra, IL-
6, and TNF-α, and 
SCFAs  
↓ postprandial insulin 
↑in fasting plasma propionate 
concentrations 
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Table 2.3 Review of Epidemiological Studies Associated with FV and WG intake and Metabolic Health 
Study What Investigating Parameters Results relating to WG, RG, and FV Improved 
health from 
WG or FV 
Bradlee et 
al. 2010 
Food group intakes 
associated with 
central obesity 
anthropometry 
among children and 
adolescents 
(covariance 
modelling with 
PROC GLM) 
3761 children 
and 1803 
adolescents with 
single 24h 
dietary recalls 
and 
anthropometric 
measures of 
central body fat 
Adolescents’ central body fat measure were 
inversely associated with grain intake. 
Central obesity adolescents consumed 
significantly less total grains and FV 
WG 
Cassidy et 
al. 2010 
Diet, lifestyle factors 
and telomere length 
(change in z score) 
2284 female 
participants 
Dietary fiber intake was positively associated 
with telomere length specifically cereal fiber 
FV was not significant 
 
WG 
D. et al. 
2003 
Examine fiber 
consumption from 
fruit, vegetable, and 
cereal sources 
(including whole 
grains and bran) is 
associated with 
incident CVD in 
elderly persons 
3588 men and 
women aged 65 
years or older 
and free of 
known CVD at 
baseline 
Cereal fiber consumption was inversely 
associated with incident CVD. Fruit and 
vegetable fiber were not associated with 
lowering CVD. 
WG 
Davis, 
Alexander et 
al., 2009 
Changes in dietary 
intake with changes 
in adiposity and risk 
factors for type 2 
diabetes 
(Partial correlations) 
Overweight 
Latino youth (n 
= 85; aged 11–
17 y) 
Increases in total dietary fiber and insoluble 
fiber were associated with decreases in visceral 
adipose tissue 
FV was not tested 
WG 
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Holt et al. 
2009 
Intakes of fruit and 
vegetables, 
antioxidants, folate, 
and total flavonoid 
with associated with 
markers of 
inflammation and 
oxidative stress 
(Spearman 
Correlations 
Coefficients) 
285 adolescent 
boys and girls, 
13-17 yrs 
Urinary F2-isoprostane was inversely correlated 
with intakes of total fruit and vegetables, vitamin 
C, beta carotene, and flavonoids.  
CRP was significantly inversely associated with 
intakes of fruit, vitamin C, and folate.  
IL-6 was inversely associated with intakes of 
legumes, vegetables, beta carotene, and vitamin 
C. 
TNF-α was inversely associated with beta 
carotene and lutein. 
WG were not tested 
FV 
Ma et al. 
2008 
Examine longitudinal 
associations between 
dietary fiber intake 
and CRP 
(simple linear 
regression analysis) 
524 subjects, 20 
and 70 y 
Inverse association between intake of total 
dietary fiber (separately for soluble and 
insoluble fiber) and CRP concentrations in both 
cross sectional and longitudinal analyses 
FV not tested 
WG 
McKeown et 
al. 2009 
Examine the 
association between 
whole and refined 
grain intake and 
measures of body fat 
distribution and  the 
relations between 
cereal, fruit and 
vegetable fiber, and 
body fat distribution  
(Multivariate-
adjusted means (95% 
CI)) 
434 free-living 
adults (177 men 
and 257 
women) aged 
between 60 and 
80 y 
Cereal fiber was inversely related to BMI, body 
fat, and trunk fat mass while fruit and vegetable 
fiber were not significant related.  
WG 
Riboli et al., 
2003 
Examine evidence 
from case-control and 
prospective studies 
Case-control or 
cohort studies 
evaluating the 
Fruit and vegetables reduce your risk of 
esophagus, lung, stomach, and colorectum 
cancer.  
FV 
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on fruit and vegetable 
intake and cancer risk 
with 
relationship 
between total 
vegetable and/or 
total fruit 
consumption 
and risk of 
cancer 
(esophagus, 
larynx, stomach, 
colon and 
rectum, breast, 
lung, and 
bladder); with 
incidence or 
mortality as the 
endpoint 
WG was not tested 
Rimm EB et 
al. 1996 
Examine the 
relationship between 
dietary fiber and 
risk of coronary heart 
disease. (Relative 
Risk (95% CI)) 
43 757 US male 
health 
professionals 40 
to 75 years 
of age and free 
from diagnosed 
cardiovascular 
disease and 
diabetes 
completed 
A 10-g increase in total dietary fiber was 
associated to decreasing your relative risk for 
myocardial infarction. When comparing fruit, 
vegetable and cereal fiber, cereal fiber was more 
associated but not significantly. 
WG 
Schulze 
2007 
Examined 
associations between 
fiber and magnesium 
intake and risk of 
type 2 diabetes 
(Relative Risk (95% 
CI)) 
9702 men and 
15 365 women 
aged 35 to 65 
years who were 
observed for 
incident 
diabetes 
Relative risk of Type 2 diabetes was 
significantly lowered with cereal fiber. Fruit 
lowered RR but not significantly. Vegetable 
fiber increased the RR for Type 2 diabetes but 
not significantly.  
WG 
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Steffen et al. 
2003 
Examine relations of 
whole-grain, refined-
grain, and fruit and 
vegetable intakes 
with the risk of total 
mortality and the 
incidence of coronary 
artery disease (CAD) 
and ischemic stroke 
(Multivariate-
adjusted hazard rate 
ratios (and 95% CIs)) 
11 940 
participants 
(4083 white 
men, 4754 
white women, 
118 8African 
American men, 
and 1915 
African 
American 
women) 
FV intake were inversely associated with 
coronary artery disease among the African 
American population but not white population. 
Whole grains were inversely associated with 
total mortality and incident of coronary artery 
disease.  
FV and WG 
van de 
Vijver et al. 
2009 
Whole grain and 
cereal fiber intake 
with BMI and risk of 
being over weight 
(Regression 
coefficients ) 
2078 men, 2159 
women, 55-66 
years old, no 
cancer 
Inverse association between WG consumption 
BMI and risk of overweight and obesity 
FV was not tested 
WG 
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Chapter 3: Promoting Gastrointestinal Health and Reducing Subclinical 
Inflammation in Overweight and Obese Individuals through Intake of Whole Grain 
Products in Comparison With Fruits and Vegetables 
Abstract 
A randomized parallel arm feeding trial was completed on forty-nine overweight 
or obese subjects with typically low intake of fruit and vegetables (FV, <2 servings/d) 
and whole grains (WG, <1 serving/d). Individuals were randomized into three groups: 
WG (3 servings/d; n=17), FV (5 servings/d; n=18), and refined grains (RG; 3 servings/d; 
n=14). Treatment foods were incorporated into the subjects’ overall diets. Stool and 
blood samples were collected at the beginning of the study and after 6 weeks. In the 
blood samples, inflammatory markers [tumor necrosis factor-α (TNF-α), interleukin-6 
(IL-6), lipopolysaccharide binding protein (LBP), and high sensitivity C-reactive protein 
(hs-CRP)] were measured. Stool sample analysis included short/branched chain fatty 
acids (S/BCFA) and microbiota composition. There was a significant decrease in LBP on 
both the WG (-0.2 μg/mL, p=0.02) and FV (-0.2 μg/mL, p=0.005) diets, with no change 
on the RG diet (0.1 μg/mL, p=0.08). The FV diet induced a significant change in IL-6 (-
1.5 pg/mL, p=0.006), but no significant change in the other treatments (RG, -0.009 
pg/mL, p=0.99; WG, -0.29, p=0.68). The WG diet resulted in a significant decrease in 
TNF-α during the intervention (-3.7 pg/mL; p<0.001), whereas no significant effects 
were found on the other diets (RG, -0.6 pg/mL, p=0.6; FV, -1.4 pg/mL, p=0.2). The 
feeding treatments induced highly individualized changes in microbiota composition such 
that treatment group differences were not identified, except for a significant increase in α-
diversity in the FV group. These data support the positive impact that WG and FV intake 
can have on metabolic health in overweight or obese individuals with normally low 
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intake of WG and FV, although it appears that these effects are mediated via different 
mechanisms
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Introduction 
Poor diet is the leading risk factor for premature death and disability in the United 
States (US Burden of Disease Collaborators, 2013). Poor diets lead to metabolic 
syndrome and its associated diseases such as heart disease and diabetes, which rank first 
and seventh among common causes of death, respectively (Xu et al., 2012). The health 
care cost of treating these chronic diseases is in excess of $600 billion annually (CDC, 
2012; CDC, 2014; Mozaffarian et al., 2015). Consequently, the government has directed 
policy towards promoting a healthier society, especially to promote healthier eating. 
There have been numerous human feeding trials showing that consuming whole 
grain (WG) or fruits and vegetables (FV) can have significant impacts on markers of 
metabolic syndrome (Martínez et al., 2013; Cooper et al, 2017; Shefin et al, 2015). 
Unfortunately, FV and WG intakes are typically far below recommended intake levles 
(US Department of Agriculture, USDA 2013). In a typical 2000 kcal diet, the current 
recommendations from the USDA are to consume 5 servings of FV and 3 servings of 
WG per day. However, in a 2015 report 76% of the US population did not meet the 
recommended intake of fruit and 87% did not meet the recommended vegetable intake 
(Latetia V. Moore et al., 2015). Over the past 5 years FV consumption has decreased by 
7% due to declines in vegetables as a side dish and consumption of juice at breakfast 
(Produce for Better Health Foundation, 2015). Likewise, a 2009-2010 survey revealed 
that only 2.9% of children/adolescents and 7.7% of adults in the US consumed at least 3 
whole grain servings/d (Reicks et al., 2014). The typical American consumes only 1 
serving of WG per day (Rehm et al., 2016).  
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There are several inflammatory mediators that can be assayed in blood as markers 
of metabolic syndrome, including tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), 
lipopolysaccharide binding protein (LBP), and high sensitivity C-reactive protein (hs-
CRP). TNF-α  is a pro-inflammatory cytokine secreted by macrophages that helps 
regulate cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation 
(Banday et al., 2017). IL-6 is a pro-inflammatory cytokine that is secreted by 
macrophages during infection after trauma to stimulate immune responses (Schafer et al., 
2007). LBP is a protein that is an acute-phase immunologic response to 
lipopolysaccharide (Banday et al., 2017). The levels of LBP in blood are a measure of 
endotoxemia. hs-CRP is secreted by the liver in response to inflammatory cytokines, and 
if most often associated with heart disease risk (Gao et al., 2004).  
The metabolic benefits of WG and FV are thought to be mediated, at least in part, 
through their interactions with the gut microbiota (Salonen, 2014; Costabile et al., 2008; 
Li et al., 2009). One way that the gut microbiota may mediate the anti-inflammatory 
effects of dietary fibers is through short chain fatty acid (SCFA) production (Brahe et al 
2013), the major metabolic end products of dietary fiber fermentation. These acids are 
known to have trophic effects locally on epithelial cell functions as well as distally via 
distribution in blood. For instance, SCFA help with maintenance of gut barrier function 
by increasing mucin production, inhibiting growth of enteropthogens, and increasing 
nutrient absorption.  Distally, SCFA are signaling molecules for carbohydrate and lipid 
metabolism. SCFA are associated with a decreased risk for cancer and obesity (Ríos-
Covián et al., 2016).  
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Typically, human feeding trials confine subjects to a single test food to determine 
its benefits on health (Basu et al., 2010; Martínez et al., 2013; Mirmiran et al., 2012; 
Sheflin et al., 2015). However, these interventions are not very practical as part of a long-
term dietary regimen to improve health. In contrast, Cooper et al., (2017) provided 
subjects with a variety of options for treatment foods.  Another option is to completely 
change someone’s diet to see if certain diets have impacts on metabolic syndrome. The 
Mediterranean diet (plant foods like fruit, vegetables, whole grains, legumes and nuts and 
replacing vegetable oils with olive oil and canola oil) has been studied to see decreases in 
lowering effects of metabolic syndrome (Michalsen et al., 2006; Romaguera et al., 2009). 
These studies focus on whole diet changes with counseling on how to cook with these 
types of foods.  Smaller changes or whole diet changes could be more sustainable for 
subjects to continue eating healthy after the study.  This purpose of this study was to 
determine the impact in participants consuming recommended amounts of whole grains 
and fruit and vegetables against a background of their typical diets on inflammatory 
makers and gut microbiota composition in overweight or obese individuals that have low 
intakes of these food groups.  
Materials and Methods 
Intervention Study 
110 individuals responded to flyers advertising this trial at grocery stores and 
University buildings and through social media advertisements. Individuals were screened 
during the initial contact period to determine if they qualified for the study and were 
interested in participating. Inclusion criteria were: body mass index (BMI) >25 kg/m2, no 
diagnosed gastrointestinal diseases, no antibiotic use for 3 months, <1 h/week of 
structured exercise, and low intake of FV and WG. BMI was calculated by measuring 
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weight and height (in light clothing without shoes). To verify a low intake of FV and 
WG, an online validated food frequency questionnaire was used (DHQII, National 
Cancer Institute, 2017). The diet survey analyzed participants’ yearly diet and included 
questions about serving size. Responses were converted to daily intake of FV or WG 
using Diet*Calc software (Bethesda, MD, USA). Sixty one individuals were excluded 
due to low BMI, high intake of FV or WG, working out regularly, recent antibiotics use, 
health reasons, or scheduling conflicts.  Fifty two participants met the inclusion criteria 
and were enrolled in the study. Three participants dropped out by the end of the study. 
The feeding trial was a randomized parallel arm design. The Institutional Review Board 
of the University of Nebraska approved all study protocols described herein (IRB 
Approval Number: 20141214525FB). Written informed consent was obtained from all 
subjects before being enrolled in the study. The clinical study was posted on 
clinicaltrials.gov.  
  Enrolled subjects were randomized into three groups: WG (3 servings/d; n=17), 
FV (5 servings/d; n=18), and refined grains (RG) (3 servings/d; n=14). Participants were 
instructed to incorporate these foods into their normal diet. The RG group served as the 
control. These subjects were supplied 3 servings/d of RG products to maintain interest 
and contact with them during the study; however, all subjects already consumed at least 3 
servings/d of RG per day as part of their normal diet. This treatment therefore represented 
minimal to no intervention. For the WG and FV treatment groups, 3 servings/d and 5 
servings/s were selected because these are the reference daily intakes (RDI) 
recommended in the US (United States Department of Agriculture, 2017) 
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One week prior to beginning the study and each week during the study 
participants visited the clinical facility. During these visits they filled out a “menu” for 
the following week. The menu consisted of a list of foods within each treatment group 
that the subjects could choose from (Table 1). These foods were commonly available at 
the local grocery store. They marked on the menu how many servings of each of the 
foods they wanted for the following week. They could choose any combination of any of 
the foods on the list, but were required to order at least 21 (WG or RG) or 35 (FV) 
servings for the week. They were allowed to order up to 44 servings of FV or 30 servings 
of WG per week if they wished.  
At all of the weekly visits during the trial period, subjects turned in several daily 
diaries that they were required to keep. One diary was a daily diet diary, which included 
intake of all test foods. The log consisted of intake of FV, WG, and RG and how many 
servings participants consumed. A secondary document was given to participants to 
discuss what constituted a serving of grain and FV. The servings from the log were 
transferred to an online database that calculated weekly amounts of FV, grains, WG, RG 
and other nutrients (United States Department of Agriculture, 2017). This diary was used 
to assess compliance to the dietary regimens. Additionally, subjects were asked to 
verbally indicate compliance when they visited the facility each week.  
 Participants also filled out a weekly GI symptom questionnaire (Appendix A.3). 
Questions consisted of number of days per week where symptoms were experienced 
together with the severity. Symptoms included stomach pains, heart burn, acid reflux, 
hunger pains, nausea, rumbling stomach, bloating, burping, flatus, constipation, diarrhea, 
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loose stools, hard stools, urgent bowels, and feeling of incomplete bowel emptying. The 
severity was rated on a 0-4 scale (0=no discomfort, slight, mild, moderate, and 4=severe).  
Biological Sample Collection and Analysis 
Stool and blood samples were collected at the beginning of the study and after 6 
weeks. The blood samples were drawn using standard venipuncture techniques by 
experienced phlebotomists from the University of Nebraska Medical Center. Blood was 
collected into two vacutainer tubes (367815, Vactutainer Serum Tubes, and 367986, 
Vacutainer Serum Separation Tubes, BD, Franklin Lakes, NJ USA). About 5 mL was 
drawn into each tube. After being collected, samples were left at room temperature for 
15-30 min to allow the blood to clot. The samples were then centrifuged (2,000 x g for 10 
min). Supernatant (plasma) was aliquoted into smaller test tubes for storage. Tubes were 
stored at -80˚C until analysis.  
TNF-α and LBP were assayed from the plasma recovered from the Vactutainer 
Serum Tubes; IL-6 and hs-CRP were assayed from the plasma recovered from the SST 
Serum Separation Tubes. All analyses were carried out using commercial ELISA kits 
according to the manufacturer’s instructions (hs-CRP: HU8817; TSZ, Waltham, MA 
USA; TNF-α: KHC3011, Invitrogen, Frederick, MD USA; IL-6: HS600B, R&D Systems 
Minneapolis, MN USA; LBP: 0628D2100, Sigma Aldrich, St. Louis, MO USA).  
Stool samples were collected using a commode collection kit (02-544-208, 
Thermo Fischer Scientific, Waltham, MA USA). An insulated cooler with ice packs was 
provided to keep samples cool until they could be delivered to the research center for 
immediate storage at -20˚ C. The samples were obtained and frozen within 2 h of 
defecation  
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 DNA was extracted using the method described in Martínez et al. (2009). Stool 
samples were thawed and 1 g of sample was diluted ten-fold in ice cold phosphate 
buffered saline (PBS). Fecal homogenates were transferred into a 2 mL sterile bead-
beating tube containing 300 mg of 0.1-mm zirconium beads, and bacterial cells were 
collected by centrifugation at room temperature at 8,000 x g for 5 minutes. The bacterial 
pellet was washed three times in ice cold PBS. The pellet was resuspended in 0.75 mL of 
lysis buffer (200 mM NaCl, 100 mM Tris pH 8.0, 20 mM EDTA) containing 20 mg/mL 
of lysozyme (611930010, ACROS Organics) and incubated at 37 °C for 30 min. Eighty 
five µL of 10% SBS solution (S0287, Teknova) and 30 µL of proteinase K 
(19133,Qiagen) (15mg/mL) was added and then incubated for 15 min at 60 °C. The pellet 
was by adding 0.5 mL of phenol:chloroform:isoamyl alcohol (25:24:1) and bead beated 
(MiniBeadbeater-8, BioSpec Products, USA) on high for 2 min. In a refrigerated (4 °C) 
centrifuge the tube was spun at 10,000 x g for 5 min. The top layer was removed into 1.5 
mL tube and 0.5 mL of phenol:chloroform:isoamyl alcohol (25:24:1) was added to the 
tube. Then the tube was spun at 10,000 x g for 5 min. The top layer was removed and put 
into a new 1.5 mL tube. This step was repeated 3 times followed and each time top layer 
was remove into a new 1.5 mL tube. 0.6 mL ethanol was added and then placed in -80°C. 
It was then centrifuged at 15,000 rpm for 20 min, whereupon the supernatant was 
discarded. The pellet was washed with 0.5 mL of 70% ethanol and was centrifuged at 
15,000 rpm for 20 min. The liquid was discarded carefully, and the DNA pellet was dried 
for 30 min at room temperature. The DNA was resuspended in 0.1 mL of tris buffer 
(10mM, pH8). The DNA pellet was then frozen at -80°C for further experiments.  
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 Sequencing was performed by University of Minnesota Genomics Center 
following the procedure by (Gohl et al., 2016). The V4-V5 region of the 16S rRNA gene 
was amplified by PCR using primers Meta_V3_F_Nextera: (5’-
CCTACGGGAGGCAGCAG-3’) 
Meta_V4_806_R: (5’-GGACTACHVGGGTWTCTAAT-3’). PCR reactions are 
performed using KAPA HiFidelity Hot Start Polymerase. After the first round of 
amplification, PCR 1 products are diluted 1:100 and 5 ul of 1:100 and then ran through a 
second PCR. Pooled, size-selected sample was denatured with NaOH, diluted to 8 pM in 
Illumina’s HT1 buffer, spiked with 20% PhiX, and heat denatured at 96C for 2 minutes 
immediately prior to loading. A MiSeq 600 cycle v3 kit was used to sequence the sample. 
Initial Filtering of Low Quality Reads. The base sequence quality information was 
confirmed by FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc). A 
stringent quality filter process was applied in which the Illumina sequence reads  with (1) 
base quality scores below the minimum quality score  (30 per base) across the whole read 
or (2) read length less than 30 nucleotides were removed using Trim Galore (ver. 0.4.0) 
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore). Note that the quality 
scores of 30 (Q30) correspond to 0.1% expected base pair call error rates. Also, any 
unknown ('N') or ambiguous nucleotide from the Illumina paired-end reads was trimmed.  
Quantitative Analysis of the Microbiome Composition. Filtered sequences were 
analyzed through the software package QIIME pipeline (ver. 1.9) (Caporaso et al. 2010); 
using scripts implemented within QIIME, paired-end reads were merged and were 
clustered into operational taxonomic units (OTUs) at a sequence similarity level of 97% 
by UCLUST (default parameter). The numerical values of the sequence reads that map to 
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OTUs were used to evaluate differences in taxonomic abundance and alpha diversities. 
The statistical differences across the samples were determined using DESeq2 (ver. 1.14) 
(Love et al., 2014) in the R Bioconductor package (http://www.bioconductor.org) (ver. 
3.1.2). OTUs to have less than 10 reads mapped were removed.  
Nucleotide sequence accession numbers. All Illumina raw sequences from this study 
were deposited in the National Center for Biotechnology Information (NCBI) Sequence 
Read Archive (SRA) under accession number pending.  
The short chain fatty acid analysis was performed on the fecal samples and 
fermented samples based on the procedure described in Pollet et al. (2012) with 
modifications. In a 2 ml plastic centrifuge tube that is immersed in ice mix together 0.4 
ml of fermented media, 0.1 ml of 7 mM 2-ethylbutyric acid in 2 M potassium hydroxide, 
0.2 ml of 9 M sulfuric acid, and 0.16 g of sodium chloride and vortex. In another 2 ml 
plastic centrifuge tube that is immersed in ice mix together 0.4 ml water, 0.1 ml of 
standard mix in 1 M potassium hydroxide, 0.2 ml of 9 M sulfuric acid, and 0.16 g of 
sodium chloride and vortex. Just before injecting onto the GC, add 0.5 ml of diethyl ether 
and shake for 30 s to 1 min. Allow layers to separate and transfer diethyl ether layer to a 
fresh screw cap microfuge tube with rubber septum. Inject 3-4 μl of diethyl ether phase 
using SCFA program on GC. 
Statistical Analysis 
All data was analyzed using ANOVA (PROC GLIMMIX) where treatment group 
was the main factor and BMI (at baseline), gender, and baseline measurement were 
covariates using SAS software (version 9.4, SAS Institute, Cary, NC, USA).  Differences 
among treatments were assessed using Tukey Test; an adjusted P < 0.05 was considered 
significant. Changes in measured variables from baseline to the end of the study within 
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each group were also assessed after correcting for BMI (at baseline), gender, and baseline 
values. The fermentation outcomes (carbohydrates and SCFA) were also analyzed using a 
binomial sign test, P < 0.05. Correlations between changes in gut bacteria and changes in 
blood parameters and formation outcomes and between changes in diet history and 
changes in gut bacteria were analyzed using Pearson correlation (PROC CORR) in SAS 
software, P < 0.05. 
Results and Discussion 
Baseline Data 
 In the randomized parallel arm feeding study 54 participated and 3 participants 
dropped out. There were no significant differences between groups at baseline except in 
fecal SCFA (Table 3.2).  
Treatment Compliance and Tolerance 
Based on diet diaries, participants in the FV and WG groups consumed an average 
of 5.7 and 3.4 servings/d of treatment foods, respectively (Table 3.3). This showed that 
participants were compliant with the treatment protocol. The diaries also showed that the 
interventions were treatment specific; e.g., subjects in the FV group were consuming low 
WG foods. Compared to other feeding trials our treatments were very modest in that 
subjects consumed the minimum recommendation of that food group. Our study focused 
on a sustainable change of the recommended amount of WG or FV with a variety options 
in the treatment group. Many participants indicated informally that they planned to 
continue trying to consume the recommended amount of FV or WG after the study 
period.  
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 Weekly gastrointestinal symptoms were recorded to track changes throughout the 
study. There were no significant changes in GI symptoms throughout the study (Table 
3.4).  
Plasma Inflammatory Markers 
The WG diet resulted in a significant decrease in TNF-α during the intervention, 
whereas no significant changes in TNF-α were found on the other treatment groups 
(Figure 3.2). Additionally, there was a significant decrease in LBP in the WG and FV diet 
with no change on the RG diet. There were no significant changes in the RG and WG 
treatments for IL-6, but there was significant decrease in FV diet. There were no 
significant changes in hs-CRP.  
The WG and FV diets had significant positive impacts on inflammatory markers. 
In particular, the change in LBP suggested a positive impact on gut barrier function. 
Lipopolysaccharide is a component of the cell walls of gram-negative bacteria; increased 
levels of LBP in the blood is suggestive of endotoxemia (Neves et al., 2013) .  
The WG diet decreased TNF-α, which was also reported by Qi et al. (2006).  In a 
study similar to ours, dietary fiber treatment decreased hs-CRP which differs from our 
results (North et al., 2009; Qi et al., 2006). In another trial, a treatment of WG rice or 
barley lowered the IL-6 in the population (Martínez et al., 2013). The FV diet was the 
only treatment that lowered IL-6.  A study by Yeon et al., (2012) a FV intervention with a 
variety of food options, similar to this study but focusing on high consumption vs small 
consumption of FV, were able to significantly reduce IL-6 and IL-1.  
Both treatment groups decreased inflammatory markers, but in different ways. FV 
decreased IL-6 and TNF-α, and WG decreased LBP and TNF-α. These different changes 
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suggest that consuming both FV and WG could have a synergistic effect to help lower 
inflammation.  
With the variety of food options it is not possible to pinpoint which component of 
the foods was responsible for the significant changes in inflammatory markers. Both 
treatment groups were good sources of dietary fiber, although the composition of the 
dietary fibers within each group are very different. The main dietary fibers in WG are ß-
glucan, arabinoxlyan, inulin and cellulose, while FV mainly contain pectin, inulin, or 
xyloglucan. FV contain more soluble fiber, and WG contain more insoluble fiber 
(Dhingra et al, 2012). WG foods can also contribute vitamin E, and phytoserols that have 
been linked to lowering parts of metabolic syndrome (Anderson et al., 2009; J. et al., 
2013; Mendiset al., 2016; Salvin, 2003), while FV include folate, flavonoids, vitamin C, 
and β-carotene, which have been inversely correlated with hs-CRP and IL-6 (Holt et al., 
2009).  
Microbiota 
There were no significant changes in fecal short chain fatty acid (SCFA) 
production during the study period (Figure 3.3). One study showed a significant increase 
in SCFAs when using a more dramatic treatment of high resistant starch (~25 g of NSP/d 
as 50 g BranPlus, 50 g cooked carrots, 50 g couscous and 2 g unprocessed bran) (McOrist 
et al., 2011). A 3 week treatment of WG cereal showed no significant difference between 
whole grain treatment and the control in SCFA production (Costabile et al., 2008), which 
compares with our data. SCFA are rapidly absorbed from the gut, which could be why 
many studies show no significant changes in SCFA production (Cummings, Pomare, 
Branch, Naylor, & Macfarlane, 1987).  
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There was a surprising significant increase in BCFAs in the FV treatment (Figure 
3.3). This suggests a shift toward protein fermentation by the microbiota. However, 
because the subjects in the FV group experienced improvements in metabolic markers 
and protein fermentation is associated with negative health outcomes, this is unlikely 
(Russell et al., 2011). Perhaps the FV treatment induced changes in the absorption of 
BCFA from microbial fermentation.  
The Firmicutes were generally higher and Bacteroidetes lower than expected 
(Cooper et al., 2017; Vanegas et al., 2017; Sheflin et al., 2015) (Figure 3.5). Similar 
studies have shown 20-40% abundance of Bacteroidetes, while this study had 7-11%. The 
differences could be due to amplification of different regions of the 16S gene or 
differences in DNA extraction protocol. Regardless, there were no significant differences 
between treatment groups or from baseline to the end of treatment. Opposing results from 
Martínez et al (2013) reported signficiant phylum-level differences in Firmicutes and 
Bacteroidetes after feeding 60 g/d of WG, which was generally more dramatic of an 
intervention than the present study. An intervention of 14g of cruciferous vegetable was 
able to shift overall bacterial community after a 14 day intake period, but no signficant 
changes in Firmicutes or Bacteroidetes (Li et al., 2009). The Firmicutes/Bacteroidetes 
may not be the best bacteria to investigate since recent reanalyzed data have been 
reporting new results that showing different relationships between 
Firmicutes/Bacteroidetes and obese populations (Shloss et al., 2016).  
There were no significant changes in individual OTUs during the treatment. This 
has been previously reported in other WG interventions with a similar experimental 
design (Cooper et al., 2017). However, FV interventions and some WG interventions 
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have shown changes in individual OTUs belonging to Roseburia and Blautia (Martínez et 
al., 2013; Sheflin et al., 2015). When OTUs were binned according to their relative fold 
change during the intervention, the WG and FV treatment groups showed a shift toward a 
decrease in some OTUs of <0.5-fold while the RG treatment group showed a shift toward 
an increase of <0.5 fold (Figure 3.5).  
The FV intervention resulted in a significant increase in α-diversity, while the 
other treatment groups did not show any differences (Figure 3.5). The wide variety of and 
new types of dietary fiber introduced to subjects’ diets in the FV treatment could have 
contributed to the increase in bacterial α-diversity in the FV group. In contrast, the WG 
diet was mainly composed of wheat-based products which contain similar dietary fibers 
to the RG products that subjects consumed as part of their habitual diet prior to the study.  
There were no significant changes in ß-diversity over the course of the study 
(Figure 3.5). Similar studies (with a wide variety diet) have also shown no significant 
differences between treatment groups (Cooper et al., 2017). During a 14 day cruciferous 
vegetables intervention there were significant changes in gut bacterial community which 
differs from our results (F. Li et al., 2009). Their stricter choice of vegetables could be 
aiding these changes.  
There were no significant changes in the microbiota at the genus level by 
treatment group, but there were individualized responses to the treatments (Figure 3.6). 
Other WG and FV interventions have shown similar results of no significant changes at 
genus level but individualized changes (Cooper et al., 2017.; J. et al., 2013).  On the 
contrary Martinez et al., (2013) showed genus level significant changes in Blautia, 
Bifidobacterium, and Dialister and Costabile et al., (2008) also saw significant changes in 
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Bifidobacterium from a WG intervention. WG diet consisted of mainly wheat based 
products. Wheat fibers can have different impacts on the gut bacteria compared to other 
whole grain fibers (De Paepe et al., 2017; Duncan et al., 2016). 
Conclusions 
A FV or WG intervention significantly reduced inflammation, but each diet 
induced changes in different markers. The FV treatment decreased IL-6 and LBP and the 
WG treatment decreased TNF-α and LBP. Both treatments had individualized effects on 
the gut microbiota, with a significant increase in α-diversity in the FV treatment. The data 
supports the positive impact that WG and FV intake can have on metabolic health in 
overweight or obese individuals with normally low intake of WG and FV, but in different 
ways.   
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Figure 3.1 Timeline of Experimental Design 
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Table 3.1: Food Options During the Treatments 
Treatment group 
What was 
served Servings 
Dietary fiber 
(g/serving) 
Fruit and Vegetables    
Banana 1 medium 2 3.9 
Apple 1 medium 2 4.4 
Clementine 2 2 2.6 
Strawberries ½  cup 1 2.9 
Blueberries ½ cup 1 1.8 
Grapes ½ cup 1 0.7 
Pear 1 medium 2 5.5 
Pepper 1 large 2 3.4 
Celery 1 stalk 1 1.2 
Broccoli ½ cup 1 1.2 
Cauliflower ½ cup 1 2.1 
Lettuce 1 cup 1 0.9 
Spinach 1 cup 1 1.4 
Peas ½ cup 1 2.3 
Tomato ½ cup 1 0.9 
Carrot ½ cup 1 2.6 
Green Beans ½ cup 1 1.4 
Average dietary fiber for 5 servings 11.5 
Whole grain    
Whole Wheat Bread 1 slice 0.8 2 
Whole Wheat Tortilla 14 in 1 tortilla 1.9 5 
Whole Wheat Tortilla 7 in 1 tortilla 1 2 
Oatmeal  1 package 1.7 3 
English Muffin 1 muffin 1.6 3 
Whole Wheat Flakes Cereal ¾ cup 1.4 3 
Ready to Eat Brown Rice 1 package 3 2 
Granola ½ cup 1.1 7 
Whole Grain Spaghetti ½ cup 3.5 6 
Toasted Oats Cereal ¾ cup 1.1 2 
Woven Wheat Crackers 5 crackers 1.5 3 
Shredded Wheat Cereal 11 biscuits 3 8 
Whole Grain Mac and Cheese Single serving 
container 
0.5 3 
Oatmeal Square 1 bar 0.9 2 
Popcorn 1 cup 1.25 6 
Sun Chips 7-11 chips 1.3 3 
Average dietary fiber for 3 servings 11.3 
Refined grain    
White Bread  1 slice 1 0 
Flour Tortilla 7 in 1 tortilla 1 1 
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Flour tortilla 14 in 1 tortilla 1 1 
Wheat Farina 1 package 1 1 
Plain Bagel large 1 bagel 1 1.3 
Plain Bagel small 2 bagel 1 0.6 
Corn Flakes ¾ cup 1 1 
Ready to eat White Rice 1 package 1 1 
Crispy Rice Cereal ¾ cup 1 0 
Spaghetti ½ cup 1 2 
Rice Flakes Cereal ¾ cup 1 0 
Buttery Crackers 5 crackers 1 0 
Crispy Rice Treat 1 bar 1 0 
Pita Chips 7-11 chips 1 1 
Mac and Cheese  Single serving 
container 
1 1 
Average dietary fiber for 3 servings  2.2 
    
The serving size for fruit and vegetables is ½ cup. For convenience participants were 
given either 1 cup or ½ cup. For instance a whole banana (1 cup) was served due to the 
inconvenience of getting a ½ banana and it going bad. FV fiber content was retrieve from 
the USDA composition database (United States Department of Agriculture, 2017). The 
serving size for whole grains is 1 ounce or 16 grams of whole grain. All servings and 
grams of whole grains were calculated by the whole grains food stamp. Some products 
more grams of whole grains were given due to convenience like a whole tortilla instead 
of a half. Refined grains were serving size was matched whole grain servings. Fiber 
serving size was retrieved from nutritional labels of the particular foods. 
  
62 
 
 
 
Table 3.2. Baseline Data 
Baseline data Groups      
  Whole Grains 
Fruit and 
vegetables 
Refined Grains  P-Value 
BMI 33.4 ± 6.5 30.5 ± 5.9 30.1 ± 5.2 0.342 
Participants 17 18 14  
 Female 11 12 7 0.153 
Male 6 6 7 0.153 
Inflammatory  
Markers 
      
IL-6 (pg/ml)  4.4 ± 1.9 4.3 ± 2.6 2.9 ± 1.5 0.5962 
TNF (pg/ml)  26.7 ± 4.17 24.2 ± 5.2 23.8 ± 5.9 0.1105 
HS-CRP (mg/ml)  0.8 ± 0.6 0.7 ± 0.4 0.6 ± 0.4 0.8853 
LBP (mg/L)  1.9 ± 0.4 1.8 ± 0.4 1.8 ± 0.3 0.3775 
Stool Short Chain  
Fatty Acids 
      
Acetate 50.4 ± 8.3 45.4 ± 7.6 75.7 ± 8.7 0.0412 
Propionate 11.2 ± 2.1 10.5 ± 1.5 23.8 ± 6.1 0.1379 
Butyrate 7.6 ± 1.5 8.4 ± 1.3 18.7 ± 3.4 0.0235 
SCFA 69.3 ± 11.7 64.7 ± 9.8 117.92 ± 17.7 0.0418 
BCFA 1.8 ± 0.3 1.6 ± 0.2 2.4 ± 0.4 0.2419 
     
The serving size for fruit and vegetables is ½ cup. It is recommended to get 5 servings a 
day of FV. The serving size for whole grains is 1 ounce or 16 grams of whole grain. It is 
recommended to get 3 servings of WG per day. Refined grains were serving size was 
matched whole grain servings. This data was analyzed through supertracker 
(SuperTracker Home, 2017). 
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Table 3.3: Average Weekly Intake of Whole Grains, Refine Grains, Fruit, and Vegetables. 
Treatment Groups Average Daily 
Intake WG 
(servings) 
Average Daily Intake 
of RG (servings) 
Average Daily 
Intake of Fruit 
(servings) 
Average Daily 
Intake of Vegetables 
(servings) 
Average Daily 
Intake of FV 
(servings) 
FV 0.9 ± 0.3b 2.4± 0.4b 3.1 ± 0.1a 2.3 ± 0.2a 5.7 ± 0.3a 
WG 3.4 ± 0.2a 2.7± 0.7b 0.8 ± 0.1b 0.6 ± 0.1b 1.4 ± 0.2b 
RG 0.7 ± 0.1b 7.1 ± 0.7a 1.4 ± 0.1b 0.6 ± 0.2b 2.0 ± 0.2b 
The serving size for fruit and vegetables is ½ cup. It is recommended to get 5 servings a day of FV. The serving size for whole grains 
is 1 ounce or 16 grams of whole grain. It is recommended to get 3 servings of WG per day. Refined grains were serving size was 
matched whole grain servings. This data was analyzed through supertracker (SuperTracker Home, 2017). 
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Table 3.4 GI Symptoms Reported at 0, 3, and 6 Weeks of FV, WG, and RG Treatment Groups. 
Subjects Stomach 
pains 
Heart  
Burn 
Acid  
Reflux 
Hunger Pains Nausea Rumbling 
Stomach 
Bloating 
Week 0 
FV  0.33 ± 0.14 0.17 ± 0.12 0.44 ± 0.22 0.77 ± 0.18 0.39 ± 0.20 0.56 ± 0.17 0.72 ± 0.21 
WG  0.24 ± 0.14 0.29 ± 0.19 0.24 ± 0.14 0.59 ± 0.19 0.32 ± 0.15 0.38 ± 0.18 0.44 ± 0.16 
RG  0.15 ± 0.15 0.15 ± 0.15 0.58 ± 0.34 0.54 ± 0.22 0 ± 0 0.46 ± 0.13 0.62 ± 0.24 
Week 3 
FV  0.5 ± 0.18 0.56 ± 0.28 0.17 ± 0.12 0.83 ± 0.19 0.67 ± 0.50 1.06 ± 0.51 0.61 ± 0.22 
WG  0.41 ± 0.17 0.35 ± 0.21 0.35 ± 0.21 0.71 ± 0.19 0.24 ± 0.18 0.74 ± 0.21 0.74 ± 0.23 
RG  0.46 ± 0.24 0.31 ± 0.21 0.38 ± 0.27 0.46 ± 0.14 0.15 ± 0.15 0.62 ± 0.24 0.62 ± 0.29 
Week 6 
FV  0.33 ± 0.20 0.22 ± 0.13 0.31 ± 0.15 0.61 ± 0.20 0.64 ± 0.29 0.58 ± 0.22 0.64 ± 0.25 
WG  0.47 ± 0.19 0.29 ± 0.16 0.06 ± 0.21 0.62 ± 0.23 0.24 ± 0.13 0.62 ± 0.18 0.47 ± 0.19 
RG  0.62 ± 0.23 0.50 ± 0.24 0.31 ± 0.06 0.59 ± 0.27 0.15 ± 0.15 0.54 ± 0.24 0.69 ± 0.24 
  
 
 
 
 
 
 
 
 
 
 
The significant difference was measured between week 0 and week 6. Severity scale was 0-4, 0 being no discomfort 
and 4 being severe. There were significant differences in number of days between bloating and diarrhea. There was no 
significant difference between severities. Participates in each group FV=18, WG-17, and RG=14. 
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Table 3.4 GI Symptoms reported at 0, 3, and 6 Weeks of FV, WG, and RG Treatment Groups. (Continued) 
 
 
 
 
 
 
Subjects Burping Flatus Constipatio
n 
Diarrhea Loose 
Stools 
Hard Stools Urgent 
Bowels 
Not Empty 
Week 0 
FV  0.28 ± 0.18 1.17 ± 0.25 0.44 ± 0.25 0.06 ± 0.06 0.44 ± 0.17 0.78 ± 0.30 0.44 ± 0.17 0.39 ± 0.17 
WG  0.47 ± 0.17 0.68 ± 0.26 0.29 ± 0.21 0.18 ± 0.10 0.53 ± 0.19  0.44 ± 0.22 0.76 ± 0.28 0.47± 0.19 
RG  0.15 ± 0.15 0.38 ± 0.18 0.5 ± 0.25 0.54 ± 0.31 0.33 ± 0.26 0.62 ± 0.29 0.31 ± 0.31 0.46 ± 0.18 
Week 3 
FV  0.17 ± 0.09 1.28 ± 0.25 0.28 ± 0.19 0.61 ± 0.23 0.56 ± 0.23 0.22 ± 0.17 1.06 ± 0.27 0.44 ± 0.18 
WG  0.38 ± 0.18 0.80 ± 0.24 0.24 ± 0.14 0.29 ± 0.21 1.00 ± 0.28  0.32 ± 0.15 0.71 ± 0.24 0.53 ± 0.23 
RG  0.31 ± 0.21 0.62 ± 0.18 0.15 ± 0.15 0.15 ± 0.15 0.38 ± 0.22 0.77 ± 0.28 0.54 ± 0.27 0.62 ± 0.24 
Week 6 
FV  0.56 ± 0.40 0.89 ± 0.23 0.36 ± 0.17 0.36 ± 0.19 0.58 ± 0.21 0.52 ± 0.24 0.64 ± 0.19 0.38 ± 0.18 
WG  0.56 ± 0.20 1.03 ± 0.27 0.41 ± 0.15 0.35 ± 0.19 0.47 ± 0.19 0.55 ± 0.23 0.71 ± 0.17 0.79 ± 0.24 
RG  0.15 ± 0.15 1.23 ± 0.75 0.23 ± 0.17 0.15 ± 0.15 0.23 ± 0.17 0.46 ± 0.22 0.23 ± 0.28 0.70 ± 0.31 
The significant difference was measured between week 0 and week 6. Severity scale was 0-4, 0 being no discomfort and 4 being severe. There 
were significant differences in number of days between bloating and diarrhea. There was no significant difference between severities. Participates 
in each group FV=18, WG-17, and RG=14.  
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Figure 3.2: Changes in Inflammatory Markers Due to Diet 
A- LBP B- TNFα C- hs-CRP D- IL-6  * < 0.05, ** < 0.01, *** < 0. 
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Figure 2.3: Changes SCFA and BCFA in Fecal Samples 
A- SCFA B- BCFA C- Propionate D- Butyrate E- Acetate 
* < 0.05, ** < 0.01, *** < 0.001 
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Figure 3.4: Changes in Phylum Level Bacteria (Note: No change were significant) 
Change in Firmicutes B- Change in Bacteroidetes C-Change in Proteobacteria D- Change in Verrucomicrobia 
 E- Change in Actinobacteria F- Change in other Phyla 
 
Change in Verrucomicrobia 
69 
 
 
0
10
20
30
40
50
O
TU
s 
(%
)
log2FoldChange
RG WG
FV
A 
B 
C 
* 
 
Figure 3.5 Changes in Gut Microbiota 
A-Log2Fold Change of OTUs B- Change in α-Diversity (Shannon’s 
Index) C- Weighted Unifrac Distance between Baseline and After 
Treatment of ß--Diversity 
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Figure 3.6: Heat Map of Log2Fold Change in dominant genera (at least 1 person with an abundance >1%) during the intervention for individual 
Participants. 
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Chapter 4: In Vitro Fermentation of Pre-digested Whole Wheat Flour with Stool 
Samples from an In Vivo Human Feeding Trial with Whole Grains and Refined 
Grains 
Abstract 
 
Previously, a human feeding trial was conducted on obese and overweight 
individual with low intake of whole grains (WG), fruit and vegetables (FV) to investigate 
the effects of increasing WG and FV on inflammation markers in the blood and gut 
microbiota. The WG treatment found significant decreases in tumor necrosis factor alpha 
(TNF-α) and Lipopolysaccharide binding protein (LBP). These decreases could be signs 
of improved gut barrier function. The purpose of this study was to use an in vitro 
fermentation system to assess the functionality of the fecal microbiota to determine if 
changes in microbiota composition and function were associated with changes in 
inflammatory markers during the feeding trial.  Pre-digested whole wheat flour was 
fermented in a batch in vitro fermentation system using stool samples collected before 
and after a dietary intervention of whole grains (WG) or refined grains (RG). There were 
no significant differences between WG and RG treatment groups for percent fermented 
carbohydrate or short chain fatty acid (SCFA) production. Fermentation of non-digestible 
carbohydrates in pre-digested whole wheat flour tended to be higher when using the fecal 
microbiota collected after the intervention compared with before (p=0.07); however, 
there was a high degree of variability among subjects. No change in fermentation of 
carbohydrates was evident in the fecal microbiota collected from subjects on the RG 
treatment. Correlation analysis among the subjects on the WG intervention showed that 
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the change in the relative abundance of Coprococcus was associated with increased 
SCFA production and decreased TNF-α and LBP during the intervention. This suggests 
that the beneficial effects of the WG intervention on markers of inflammation may have 
been due to increased capacity of the gut microbiota to ferment dietary fibers and produce 
beneficial SCFAs.
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Introduction 
It is difficult to assess the metabolic activity of the human gut microbiota.  In vitro 
fermentation can be a tool to assess the functionality of the microbiota in terms of its ability 
to ferment certain substrates and produce metabolites that are associated with human health 
(Smidt etl al., 2009). In a recent study, increased carbohydrate fermentability and butyrate 
production came from people consuming higher quality diets compared to low quality diets 
(Brahma et al., 2017). Certain bacteria will colonize better with certain fiber; for instance, 
inulin is a better substrate for Ruminococcus, Faecalibacterium prausnitzii, and Prevotella 
copri, while wheat bran increased Eubacterium xylanophilum and members of 
Lachnospiraceae (De Paepe et al., 2017; Duncan et al., 2016). 
Quality of diet and particular fibers can alter the gut bacteria, but what is not 
known is how these fibers affect gut bacteria and metabolic benefits. Some previous 
investigators have used in vitro fermentation to help explain results found in in vivo 
studies. Koecher et al., (2014) and Bliss et al., (2013) tried to link the benefits between in 
vivo and in vitro, but both studies found that their results were not significantly related to 
improved dietary in vitro fermentation through an in vivo supplementation. Daniel et al. 
(1997) and Wisker et al. (1998) were able to show that using mixed diet (mixtures of 
dietary fibers in intact food) and non-starch polysaccharide (NSP) in vitro can give 
sufficient accuracy compared to in vivo testing. When using intact or whole food rather 
than individual dietary fibers in vivo and in vitro can be connected to understand the 
connection between gut bacteria and metabolic outputs. 
Through in vitro fermentation outcomes, correlations can be suggested about diet 
and gut bacteria in response to metabolic health. A study analyzed eighteen subjects and 
80 
 
 
 
P
age8
0
 
correlated dietary records with dietary fiber degradation and short-/branched-chain fatty 
acid (BCFA) and ammonia production during in vitro fecal fermentation. It was found 
that butyrate was correlated with fecal donor intake of some nutrients which were 
contributed to grain, nut, and vegetable based foods while BCFA production was 
correlated with intake of unsaturated fatty acids (Yang et al., 2014).  These types of 
correlations help link the relationship between gut bacteria, diet, and human health.  
In a previous study, a human feeding trial was conducted on obese and 
overweight individuals with low intake of WG, fruit and vegetables FV to investigate the 
effects of increasing WG and FV on inflammation markers in the blood and gut 
microbiota. Participants consumed 3 servings of whole grains a day or 3 servings of RG a 
day. The WG treatment resulted in significant decreases in tumor necrosis factor alpha 
(TNF-α) and lipopolysaccharide binding protein (LBP). Presently, an in vitro 
fermentation experiment was performed to assess the changes in functionality of the 
microbiota following a WG and RG intervention. Correlations were analyzed to examine 
relationships between diet, gut microbiota, and fermentation outcomes. 
Materials and Methods 
Subjects, Dietary Records, and Stool Sample Collection 
In chapter 3, dietary records and stool samples were collected from 31 
participants from the RG and WG treatment groups. This population had not taken 
antibiotics in the last six months, had low intake of FV (<2 servings/d) and WG (<1 
serving/d), had a BMI over 25, and did not participate in structured activity. Stool 
samples and dietary records were collected as described in chapter 3. All protocols 
involving human subjects were approved by the University of Nebraska-Lincoln's Institutional 
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Review Board before initiation of the study (no. 20141214525FB) All subjects gave 
voluntary informed consent before enrollment in this project. 
 
In Vitro Starch Digestion and Fermentation 
Wheat samples (cultivar NW15677) were milled in a Butler mill to separate and 
collect bran and flour. Cyclone grinder was used to grind bran to 1 mm, then the flour 
and bran was mixed. The milled samples were then subjected to in vitro digestion 
according to Yang & Rose 2014.  
In vitro batch fermentation was performed based on the procedure described in 
Yang & Rose, 2014. Two batch 12 h fermentations were completed using stool samples 
at baseline and stool samples after the 6 week intervention. The results from the baseline 
fermentation were correlated with subject measurements at baseline. The changes in 
fermentation outcomes between the two fermentations were correlated with changes 
during the intervention. 
Fermentation Analysis 
The short chain fatty acid analysis was performed on the fecal samples and 
fermented samples based on the procedure described in Pollet et al. (2012). The soluble 
and insoluble carbohydrate analysis was performed based on the procedure described in 
Arcila et al. (2015).  
Statistical Analysis 
All data was analyzed using ANOVA (PROC GLIMMIX) where treatment group 
was the main factor and BMI (at baseline), gender, and baseline measurement were 
covariates using SAS software (version 9.4, SAS Institute, Cary, NC, USA).  Differences 
among treatments were assessed using Tukey Test; an adjusted P < 0.05 was considered 
significant. Changes in measured variables from baseline to the end of the study within 
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each group were also assessed after correcting for BMI (at baseline), gender, and baseline 
values. The fermentation outcomes (carbohydrates and SCFA) were also analyzed using a 
binomial sign test, P < 0.05. Correlations between changes in gut bacteria and changes in 
blood parameters and fermentation outcomes and between changes in gut bacteria were 
analyzed using Pearson correlation (PROC CORR) in SAS software, P < 0.05. Baseline 
diet history was correlated with fermentation outcomes using Spearman partial 
correlations with partial variables with energy intake, age, gender, and BMI.  
Results and Discussion 
Baseline Correlations 
Correlations were performed on baseline diet and fermentation outcomes using 
the fecal microbiota collected at baseline to determine if subjects’ diets before the study 
were associated with in vitro fermentation outcomes (Table 4.1). The correlations 
revealed a relationship between carbohydrate quality and SCFA production: diets high in 
dietary fiber were associated with higher SCFA production, especially butyrate, whereas 
diets high in sugar were associated with reduced SCFA production. “Healthy fat” (ω-3; 
polyunsaturated) intake was also positively related to SCFA production during the in 
vitro fermentation. Intake of several vitamins and minerals were also correlated with the 
SCFA.  
These correlations were similar to Yang et al. (2014), but in a different 
population. Yang et al. (2014) comprised a generally younger population with lower BMI 
while this study included older adults with higher BMI. The median age in this study was 
31 and mean BMI was 30, while Yang et al., (2014) had a median age of 24 and median 
BMI of 25. Interestingly, although many of the correlations were similar between the two 
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groups, production of SCFA, especially butyrate, was much lower in the present 
population compared with the previous, healthier population (Figure 4.1). 
Correlations were performed between microbiota composition and fermentation 
outcomes using baseline fecal samples (Table 4.2). Butyrate showed the most 
correlations with microbiota composition, mainly with members of the Firmicutes 
phylum. An unclassified genus in the Ruminococaceae family, Faecalibacterium, and 
Dialister were highly correlated with SCFA and are known butyrate producers (Brahe et 
al.,  2013; Scott et al., 2014). Notably, Faecalibacterium abundance was positively 
correlated with nearly every fermentation outcome, including the fermentation of the 
non-digestible carbohydrate fractions. Unexpectedly, Lachnospira was highly correlated 
with SCFA production, including butyrate. Lachnospira are not butyrate producers but 
may be important cross-feeding partners with butyrate producers (Cornick et al., 2015).  
Two similar studies have found comparable results when looking at changes in 
gut microbiota in grain based dietary fiber. Brahma et al. (2017) found Faecalibacterium 
was positively correlated with butyrate and Ruminococaceae was negatively correlated 
with acetate and SCFA. In another study investigating the in vitro fermentation of six 
dietary fibers, Faecalibacterium was positively correlated with SCFA (Yang et al., 2013). 
Yang et al. (2013) also had some conflicting results to the present study: 
Faecalibacterium was negatively correlated with acetate, and Blautia also had opposite 
correlations. The differences in correlations may be due to the different types of 
substrates under study.  
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Changes in Fermentation Outcomes Using Stool Samples from Before and After the 
Intervention 
Pre-digested whole wheat flour was fermented in a batch in vitro fermentation 
system using stool samples collected before and after dietary intervention. Initially, there 
were no significant changes in percent carbohydrate fermented during in vitro 
fermentation when comparing before and after each intervention (Figure 4.2). However, 
it was evident that there was a high degree of inter-individual variability and, for many 
fecal samples from the WG group, the percent carbohydrate fermented at week 6 was 
higher than at baseline. Indeed, a binomial sign test indicated that the percent 
carbohydrate fermented after the intervention tended to be higher compared with week 0 
for individuals in the WG group (p=0.07). Such was not the case for fecal samples 
collected from individuals in the RG group (p=0.29). Thus, this suggests that the 
microbiota tended to be able to ferment more WG dietary fibers after the intervention 
compared to before the intervention.   
The % fermentable CHO at baseline is negatively correlated with the change in 
fermentable CHO across time points (r=-0.71) (Figure 4.3). This relationship is also true 
for butyrate production (r=-0.81). These correlations are not significant for any other 
fermentation outcomes. This indicates that people with low ability to ferment CHO (or 
produce butyrate) at baseline showed an increase with the WG treatment, while those 
with a high capacity to ferment CHO (or product butyrate) at baseline did not improve 
further. This is very common. For instance, individuals with very high Bifidobacterium at 
baseline typically do not increase further when administered a prebiotic ( Davis et al., 
2011).  
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There were no significant differences in SCFA or BCFA production between 
fermentations performed using stool samples from week 0 and week 6, regardless of 
intervention (Figure 4.5). Brahma et al., (2017) found a significant difference in SCFA 
between a high quality diet and a low quality diet. Subjects were divided into groups 
based on habitual diet quality. Perhaps the lack of change in the present study is because 
the intervention was not long enough or was not severe enough.  
Being able to link the results of an in vivo study with the results from an in vitro 
has been the subject of a few previous studies. Bliss et al. (2013) found that 
supplementation of dietary fibers of psyllium, gum arabic, and carboxymethylcellulose 
could not significantly increase degradability of fiber using batch in vitro system. Daniel 
et al. (1997) and Wisker et al. (1998) both used mixed intake fiber diets rather than single 
fibers as the substrate. When comparing in vivo and in vitro it was found fermentation 
outcomes were similar when assaying carbohydrate fermentation from the whole diet. 
However, when estimating carbohydrate fermentation from an isolated fiber there were 
large differences between in vivo results and in vitro fermentation. Thus, in vitro 
fermentation experiments tend to agree well with in vivo outcomes when using intrinsic 
and intact dietary fibers as opposed to isolated dietary fibers.  
Correlations between changes in fermentation outcomes and inflammatory markers 
during the intervention 
Correlations were performed on changes in bacteria with the changes in blood 
markers and fermentation outcomes of pre-digested wheat flour with the WG treatment. 
Changes in only one genus was significantly correlated with both inflammatory markers 
that showed significant decreases during the intervention (TNF-α and LBP) and several 
fermentation outcomes: Coprococcus (Table 4.3).  
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These correlations suggest a connection between changes in gut microbiota 
composition (specifically changes in Coprococcus) and function (specifically SCFA 
production) during the intervention and reduction in inflammatory markers during the 
intervention (Figure 4.6). Corpococcus are gram positive  chemoorganotrophs known to 
produce butyrate and propionate (Ezaki et al., 2015). A review discussed that microbiota-
generated SCFAs are associated with reduced risk of inflammation (Rial et al.,2016).  
Correlations were performed between changes in inflammatory markers, fecal 
microbiota, and in vitro fermentation results during the RG intervention (Table 4.4). 
Dorea, Bacteroides, Parabacteroides, Oscillopsira, and Dialister had negative 
correlations with IL-6. Corobacteriacea, Ruminococcus, and Lactobacillus had positive 
correlations with IL-6. Bifidobacterium was negatively correlated with TNF-α, 
propionate, and butyrate. Because the RG intervention introduced no dietary intervention 
to the subjects and there were no significant changes in inflammatory markers during the 
study, the relevance of these correlations may be minimal. 
Conclusions 
Baseline correlations found that diets high in dietary fiber, ω-3 fatty acids, and 
polyunsaturated fatty acids and several vitamins and minerals are associated with higher 
SCFA production. It was also found that Ruminococaceae family, Faecalibacterium, and 
Dialister are highly correlated with SCFA production during fermentation. After a WG 
intervention, the microbiota tended to ferment more CHO after the WG intervention, but 
was related to baseline ability of the microbiota to ferment carbohydrates. Such was also 
true for butyrate production. Correlations between results from the intervention trial and 
the in vitro fermentation suggested a link between changes in the composition and 
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function of the microbiota and changes in inflammatory markers. Coprococcus appeared 
to play a central role in the production of SCFA during fermentation of carbohydrates and 
subsequent reduction in TNF-α and LBP. These data show that in vitro fermentation can 
help develop hypotheses explaining the relationship between diet, metabolic health, and 
gut bacteria.  
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Table 4.1 Correlations between results from in vitro fermentation of pre-digested whole wheat flour and habitual nutrient intake of the 
fecal donor; SCFA, short chain fatty acids; BCFA, branched chain fatty acids; ferm., fermented (%); AX, arabinoxylan; N SP, non-
starch polysaccharides; N=31; *p<0.05; **p<0.01.   
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Table 4.2 Correlations between results from in vitro fermentation of pre-digested whole wheat flour and fecal microbiota composition 
of the stool donor; SCFA, short chain fatty acids; BCFA, branched chain fatty acids; ferm., fermented (%); cell, cellulose; AX, 
arabinoxylan; NSP, non-starch polysaccharides; only taxa of which at least 1 person had a relative abundance >1% are shown; N=31; 
*p<0.05; **p<0.01.   
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Figure 4.2 Total Carbohydrate Percent Fermentation in vitro Fermentation of Pre-
digested Wheat Flour 
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Figure 4.4 SCFA and BCFA Production during in vitro Fermentation  
with Pre-digested Wheat Flour (Note: Not Significant) 
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Table 4.3. Correlations between results from in vitro fermentation of pre-digested whole wheat flour with WG treatment, blood 
markers, and fecal microbiota composition of the stool donor; SCFA, short chain fatty acids; BCFA, branched chain fatty acids; ferm., 
fermented (%); cell, cellulose; AX, arabinoxylan; NSP, non-starch polysaccharides; only taxa of which at least 1 person had a relative 
abundance >1% are shown; N=31; *p<0.05; **p<0.01.   
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TNF-α             **  *     
 *  *                           
LBP             *       
 
         *                    
IL-6                    
 
                             
hs-CRP                    
 
                             
Acetate *  *      *    **       
 
                    *         
Propionate                    
 
                           *  
Butyrate         *           
 
   *                        **  
SCFA *        *    *       
 
                             
BCFA            **        
 
       **            *          
Cellulose ferm.                    
 
                             
AX ferm.                  **  
 
              ** *              
NSP ferm.                  *  
 
              *               
Key (phylum)   Actinobacteria   Bacteroidetes    Firmicutes   Proteobacteria   Tenericutes   Verrucomicrobia            
Key (r) -0.65                   0.67                                                                        
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Table 4.4 Correlations between results from in vitro fermentation of pre-digested whole wheat flour with RG treatment, blood 
markers, and fecal microbiota composition of the stool donor; SCFA, short chain fatty acids; BCFA, branched chain fatty acids; fer., 
fermented (%); cell, cellulose; AX, arabinoxylan; NSP, non-starch polysaccharides; only taxa of which at least 1 person had a relative 
abundance >1% are shown; N=31; *p<0.05; **p<0.01.   
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TNF-α 
 
** 
                
** 
         
* 
                   
LBP 
           
** 
                 
** 
                  
IL-6 
  
** 
 
* * ** 
        
* 
 
* 
     
* 
   
** 
        
** 
           
hs-CRP 
               
* 
                    
* * 
          
Acetate 
          
* 
                   
* 
                 
Propionate * * 
                         
* 
                    
Butyrate 
 
* 
        
* 
                   
* * 
            
* 
   
SCFA 
          
* 
                   
* 
                 
BCFA 
 
* 
                                           
* 
  
Cellulose 
ferm. 
                                                
AX ferm. 
                                 
* 
        
* 
     
NSP ferm. 
       
* 
                         
** 
 
* 
    
* 
 
* 
     
Key 
(phylum)   Actinobacteria   Bacteroidetes   Firmicutes   Proteobacteria   Tenericutes   Verrucomicrobia            
Key (r) -0.72                  0.77                                                                       
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Chapter 5: Conclusions 
Conclusions 
Based on whole grain (WG) and fruit and vegetable (FV) epidemiological and 
intervention studies, I hypothesized that the WG intervention will be as effective in 
improving beneficial bacteria and reducing subclinical inflammation as a FV 
intervention, both of which will be better than RG. To test this hypothesis I conducted a 6 
week feeding trial with WG, FV, and RG. Inflammatory markers and stool samples were 
analyzed before and after the 6 week intervention.  The data did support half of my 
hypothesis. The WG and FV treatments were effective in reducing subclinical 
inflammation compared to the RG treatment. The data did not support the hypothesis that 
there were equal treatment effects, but both treatments showed significant decreases in 
inflammatory markers. However, their effects may not be equivalent because the markers 
that were decreased were different depending on intervention group. Based on differing 
effects on inflammatory markers, I now hypothesize that WG and FV are both anti-
inflammatory but by different mechanisms.  
Through in vitro studies from the literature I hypothesized that the fecal 
microbiota collected from subjects after a WG intervention will be better able to ferment 
the dietary fibers in whole wheat and produce butyrate compared with before the 
intervention. The data showed a trend toward higher carbohydrate fermentation after the 
WG intervention, but there was a lot of individual variation. There was not a significant 
increase in butyrate production. Differences in SCFA production were correlated with 
changes in inflammatory markers during the intervention.  With these data I now 
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hypothesize that the change in Coprococcus improves inflammation by fermenting whole 
grain dietary fiber. I also hypothesize that increased SCFA production is responsible for 
certain decreases in inflammatory markers. 
Changes to the Experiment 
 The experimental design of this project was fabricated well, but there are slight 
changes that could have made the experiment more successful or controlled. Recruiting 
participants was a struggle due to finding overweight people who were not trying to get 
healthy. Most overweight people either work out or are trying to achieve a healthier diet. 
The number of participants was slightly lower than anticipated. By having a larger 
sample of participants more changes may have been identified.  
 The interventions were very modest. Participants could choose from 11-15 
different options. In other WG or FV clinical treatments more strict diets and 
interventions were enforced (Costabile et al., 2008; J. et al., 2013; Martínez et al., 2013). 
With these strict interventions investigators knew exactly what they were eating and 
could also correlate individual nutrient components from that food to parameters in the 
study. With my interventions I was not able to pinpoint if the change in IL-6 was from a 
particular food. Conclusions could only be made that whole grain products or fruit and 
vegetable products are making those changes. Future clinical interventions should have 
specific food interventions like 1 slice of bread or 1 cup of rice a day.  
 During the study participants were supposed to continue with their regular diets, 
which were already low in whole grains and fruit and vegetables. There was no 
restriction on what they could and could not eat besides FV and WG.  I assumed that 
subjects did not change their normal diet, but there are other foods in the diet (fermented 
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products, yogurt, seeds, and certain oils) that can be contributing to changes in gut 
microbiota and immune response markers. By not allowing these types of foods maybe 
the results would have changed a certain way.  
 The in vitro fermentation experiment did not show many significant results. The 
experiment had a very small sample size, but with a larger sample size potentially more 
significance results could be found. The fermentation time could have not been long 
enough.  In a similar study with a fermentation time of 24 hrs more fermentation and 
SCFA production occurred (Brahma et al., 2017). In the in vivo experiment more 
dramatic treatments of 5 servings of WG or a single treatment of rye bread could change 
more of the functionality of the bacteria for the in vitro fermentation. With a larger 
sample size, dramatic intervention, or longer fermentation time potentially more changes 
may have been significant.  
Future Research 
 From our results there are different future experiments that can be completed. It 
was shown that whole grains and fruit and vegetables decrease inflammation but in 
different mechanisms. There could be a synergistic effect happening with these two food 
products. I would propose to perform a similar intervention with RG as the control but 
have 1 treatment group of participants consuming their RDI of whole grains and fruit and 
vegetables to see how inflammation or gut bacteria changes.  
 Another clinical trial that could be completed is have 6 treatment groups looking 
at refined grains, the RDI of whole grains or fruit and vegetables, combining the RDI of 
whole grains, fruit and vegetables, and doubling the RDI of whole grains or fruit and 
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vegetables. It would be interesting to see how over consumption of WG or FV compares 
to control diet and the normal RDI of WG and FV.
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Appendix 
Methods 
Blood serum was sent to UNL Biomedical and Obesity Research Core (BORC) to 
be analyzed for glucose, cholesterol, magnesium, Triglycerides, and HDL using the 
Vitros-250 chemistry analyzer.  
Results and Discussion 
During testing of the plasma markers, it was shown that some of the participants 
had elevated glucose levels. This could be from not having a fasting blood sample. Non 
fasting blood sample will only effect the plasma markers and should not affect the 
inflammatory markers. During the analysis the participants with the evaluated glucose 
levels were taken out of the fasting plasma analysis.  
As described in Table 1 there were evaluated glucose levels that would affect the 
analysis of the fasting blood samples. Figure 1 shows the change in the blood parameters. 
There were no significances between treatment groups. This data was very inconclusive 
due to the limiting participants that had a low enough glucose level to be considered a 
fasting blood sample. A similar study that had a 3 week treatment of whole grain 
breakfast cereal showed no significant differences between control and treatment diet in 
HDL, cholesterol, and glucose levels.  
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Table A.1 Baseline Data 
Baseline data Groups    
 Whole Grains Fruit and 
vegetables 
Refined Grains P-Value 
Fasting Plasma markers*     
Glucose (mg/dL) 88 ± 13.75 92.29 ± 2.21 92.14 ± 7.13 0.9385 
Cholesterol (mg/dL) 170.33 ± 33.50 166.57 ± 29.29 141.71 ± 17.03 0.9676 
Magnesium (mg/dL) 1.93 ± 0.23 1.9  ± 0.15 1.79  ± 0.11 0.9051 
Triglycerides (mg/dL) 98.33 ± 36.50 100.43  ± 28.47 74.14 ± 22.87 0.6163 
HDL (mg/dL) 61.67  ± 10.41 61.86  ± 17.92 52.0 ± 12.62 0.5888 
Participants FV=7 WG=3 RG=7. 
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A B 
C D 
E 
Figure A.1: Changes in Blood Markers Due to Diet  
A- Cholesterol B- Glucose C- Magnesium D- Triglycerides E- HDL * < 0.05, ** < 0.01, *** < 0.001 
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Table A.2 FV Menu 
choose 2 1/2 cups to 3 cups- put either 1, 2 or 1/2 on each day you want that item      
Food Wednesday Thursday Friday Saturday Sunday Monday Tuesday Frozen Fresh Can 
1 cup 
equivalent 
1/2 cup 
equivalent 
Fruit             
Banana           large  small 
Apple           large  medium 
Oranges/ cutie          orange cutie 
Strawberries          1 cup 1/2 cup 
Grapes           32 grapes 16 grapes 
Pear           1 1/2 pear 
Veggies             
             
Pepper           1 pepper 1/2 pepper 
Celery           2 stalks 1 stalk 
Broccoli           
91 g or 3 
spears 45 g 
Cauliflower          107 g 53 g 
Lettuce           2 cup 1 cup 
Spinach           2 cup 1 cup 
Peas           1 cup 1/2 cup  
Tomato           1 large 
8 cherry 
tomato 
Baby Carrot          12 6 
Green Beans          1 cup 1/2 cup  
max 44 to 42            
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Table A.3 WG Menu 
Choose 3-4 servings per 
day         
Food 
Wednesda
y 
Thursda
y Friday Saturday 
Sunda
y Monday 
Tuesda
y 
Serving size equivalent 
to 1 
Sara Lee Whole Wheat 
Bread        1 slice=1 
Mission Whole Wheat 
Tortilla        7 in 
Oatmeal        1 packet=1 
English Muffin        Mini vs Big 
Wheaties Cereal        3/4 cup 
Ready to Eat Brown Rice        uncle Bens 
Granola        48 g 
whole grain Spaghetti         1/2 cup=1 serving 
Cheerios Cereal        3/4 cup 
Triscuit Crackers        5 chips 
Mini Wheats        11 biscuits 
Mac and Cheese        Individual or box 
Oat Bar        1 square 
Popcorn- Boom Chicka 
Pop        21 g 
Sun Chips        7-11 chips 
Max 30 servings         
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Table A.4RG Menu 
Choose 3-4 servings per 
day         
Food Wednesday Thursday Friday Saturday Sunday Monday Tuesday 
Serving size equivalent 
to 1 
Sara Lee White Bread         1 slice=1 
Mission Flour tortilla        14 in 
Mission Flour tortilla        7 in 
Cream of Wheat        1 packet=1 
Plain Bagel        mini vs big 
Corn Flakes        3/4 cup 
Uncle Bens Ready to eat 
White Rice        1 package 
Rice Krispies Treats         1 
Spaghetti        1/2 cup=1 serving 
Special K Cereal        3/4 cup 
Town House Ritz 
Crackers        25 g 
Rice Krispies        3/4 cup 
Pita Chips        10-11 chips 
Mac and Cheese        box vs individual 
Max 30 servings per week         
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Week  Participant ID    
Fill out as accurately as possible. Estimate serving sizes using the serving card provided. 
Do not forget condiments, snacks, and beverages. 
 
Date Meal Item Amount Additional information 
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
Figure A.2: Diet Diary 
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Figure A.3 Gastrointestinal Symptom Rating Scale 
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Figure A.4 Recruitment Flyer 
